Baxalta Incorporated v. Genentech, Inc.
1:17-cv-00509
Overview
Case Number
1:17-cv-00509
Filing Date
2017-05-04
Status
Terminated
Termination Date
2019-02-01
Court
District Court, D. Delaware (ded)
Presiding Judge
Timothy Belcher Dyk
Nature of Suit
830 Patent
Jurisdiction Type
Federal Question
Cause of Action
35:271 Patent Infringement
Jury Demand
Plaintiff
Parties
Movant
Patients for Access to Advanced Hemophilia Therapy
Represented By
1 Attorneys ListedPatients for Access to Advanced Hemophilia Therapy
c/o Mark Antell
1573-301 N. Colonial Terrace, Arlington, VA 22209
Defendant
Chugai Pharmaceutical Co., Ltd.
Represented By
6 Attorneys ListedShaw Keller LLP
Tel: +1 (302) 298-0700
1105 North Market Street, 12th Floor, Wilmington, DE 19801
JPMorgan Chase & Co.
Tel: +1 (302) 455-3374
JPMorgan Chase & Co., 4041 Ogletown Stanton Road
Baxalta Incorporated
Represented By
15 Attorneys ListedMorgan Lewis & Bockius LLP
Tel: +1 (302) 574-3000
Fax: +1 (302) 574-3001
1007 Orange Street, Suite 501
Plaintiff
Baxalta GmbH
Represented By
14 Attorneys ListedMorgan Lewis & Bockius LLP
Tel: +1 (302) 574-3000
Fax: +1 (302) 574-3001
1007 Orange Street, Suite 501
Third Party Plaintiff
Genentech, Inc.
Represented By
12 Attorneys ListedAshby & Geddes
Tel: +1 (302) 654-1888
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Timothy Belcher Dyk
Patents Involved
There is a single patent involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | US7033590 |
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
1
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Civil Cover Sheet)(rwc) (Entered: 05/04/2017)
2017-05-04
2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 05/04/2017)
2017-05-04
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,033,590. (rwc) (Entered: 05/04/2017)
2017-05-04
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Shire plc for Baxalta Incorporated; Corporate Parent Baxalta Incorporated for Baxalta GmbH filed by Baxalta GmbH, Baxalta Incorporated. (rwc) (Entered: 05/04/2017)
2017-05-04
1
No Summons Issued. (rwc)
2017-05-04
1
No Actions
No Summons Issued
2017-05-04
1
No Actions
Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)
2017-05-10
1
No Actions
Case Assigned/Reassigned
2017-05-10
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # 2 Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # 3 Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # 4 Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # 5 Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # 6 Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm) (Entered: 05/11/2017)
2017-05-11
1
Summons Issued
2017-05-11
1
No Actions
Summons Issued with Magistrate Consent Notice attached as to Genentech, Inc. on 5/11/2017. (sar)
2017-05-11
1
No Actions
Return of Service Executed by Baxalta Incorporated, Baxalta GmbH. Genentech, Inc. served on 5/11/2017, answer due 6/1/2017. (Connolly, Colm) (Entered: 05/12/2017)
2017-05-12
1
SO ORDERED - re 5 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 5/16/2017. (mdb)
2017-05-16
1
No Actions
Add Attorneys - PHV only
2017-05-16
1
No Actions
SO ORDERED
2017-05-16
1
No Actions
Add Attorneys Pro Hac Vice
2017-05-16
1
No Actions
Pro Hac Vice Attorney Amanda S. Williamson for Baxalta GmbH,Amanda S. Williamson for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-05-16
1
No Actions
Add Attorneys - PHV only
2017-05-22
1
No Actions
Pro Hac Vice Attorney Jennifer M. Dienes,Maria E. Doukas for Baxalta GmbH,Jennifer M. Dienes,Maria E. Doukas for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-05-22
1
No Actions
Add Attorneys Pro Hac Vice
2017-05-22
1
No Actions
STIPULATION TO EXTEND TIME by which defendant Genentech, Inc. must answer, move, or otherwise respond to the complaint to June 30, 2017, - filed by Genentech, Inc.. (Balick, Steven) (Entered: 06/01/2017)
2017-06-01
1
SO ORDERED - re 7 STIPULATION TO EXTEND TIME by which defendant Genentech, Inc. must answer, move, or otherwise respond to the complaint to June 30, 2017, filed by Genentech, Inc., Set/Reset Answer Deadlines: Genentech, Inc. answer due 6/30/2017. Ordered by Judge Gregory M. Sleet on 6/1/2017. (mdb)
2017-06-01
1
No Actions
SO ORDERED
2017-06-01
1
No Actions
~Util - Set/Reset Answer Deadline AND SO ORDERED
2017-06-01
1
No Actions
Summons Issued
2017-06-02
1
No Actions
Summons Issued with Magistrate Consent Notice attached as to Chugai Pharmaceutical Co., Ltd. on 6/2/2017. (nmg)
2017-06-02
1
No Actions
WAIVER OF SERVICE returned executed by Baxalta Incorporated, Baxalta GmbH: For Chugai Pharmaceutical Co., Ltd. waiver sent on 6/15/2017, answer due 9/13/2017. (Connolly, Colm) (Entered: 06/20/2017)
2017-06-20
1
ANSWER to 1 Complaint,, with Jury Demand, COUNTERCLAIM against Baxalta GmbH, Baxalta Incorporated by Genentech, Inc..(Balick, Steven) (Entered: 06/30/2017)
2017-06-30
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Balick, Steven) (Entered: 06/30/2017)
2017-06-30
1
MOTION for Pro Hac Vice Appearance of Attorney Nicholas P. Groombridge, Eric Alan Stone, Kenneth A. Gallo, Jennifer Gordon, Ph.D., and David E. Cole - filed by Genentech, Inc.. (Balick, Steven) (Entered: 06/30/2017)
2017-06-30
1
Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Mayo, Andrew) (Entered: 06/30/2017)
2017-06-30
1
ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 7/5/2017. (asw) (Entered: 07/05/2017)
2017-07-05
1
Pro Hac Vice Attorney Eric A. Stone for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-07-06
1
No Actions
SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Nicholas P. Groombridge, Eric Alan Stone, Kenneth A. Gallo, Jennifer Gordon, Ph.D., and David E. Cole filed by Genentech, Inc. Signed by Judge Gregory M. Sleet on 7/6/2017. (asw)
2017-07-06
1
No Actions
Add Attorneys - PHV only
2017-07-06
1
No Actions
Add Attorneys Pro Hac Vice
2017-07-06
1
No Actions
SO ORDERED
2017-07-06
1
No Actions
Add Attorneys - PHV only
2017-07-10
1
No Actions
Add Attorneys Pro Hac Vice
2017-07-10
1
No Actions
Pro Hac Vice Attorney Jennifer Gordon, David E. Cole, Kenneth A. Gallo for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)
2017-07-10
1
No Actions
ANSWER to 9 Answer to Complaint, Counterclaim by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm) (Entered: 07/21/2017)
2017-07-21
1
Joint STATUS REPORT by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) (Entered: 08/04/2017)
2017-08-04
1
PROPOSED ORDER - Scheduling Order by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) (Entered: 08/04/2017)
2017-08-04
1
Amended STATUS REPORT (Submitted Jointly) by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) Modified on 8/14/2017 (mdb). (Entered: 08/04/2017)
2017-08-04
1
Add Attorneys - PHV only
2017-08-14
1
No Actions
Add Attorneys Pro Hac Vice
2017-08-14
1
No Actions
Pro Hac Vice Attorney Nicolas P. Groombridge for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2017-08-14
1
No Actions
MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Chugai Pharmaceutical Co., Ltd.. (Attachments: # 1 Text of Proposed Order)(Fry, David) (Entered: 09/13/2017)
2017-09-13
1
OPENING BRIEF in Support re 18 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Chugai Pharmaceutical Co., Ltd..Answering Brief/Response due date per Local Rules is 9/27/2017. (Fry, David) (Entered: 09/13/2017)
2017-09-13
1
DECLARATION of Tetsuya Yamaguchi re 18 MOTION to Dismiss for Lack of Jurisdiction Over the Person by Chugai Pharmaceutical Co., Ltd.. (Fry, David) Modified on 9/14/2017 (mdb). (Entered: 09/13/2017)
2017-09-13
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd. for Chugai Pharmaceutical Co., Ltd. filed by Chugai Pharmaceutical Co., Ltd.. (Fry, David) (Entered: 09/13/2017)
2017-09-13
1
MOTION for Pro Hac Vice Appearance of Attorney David C. Doyle and Brian M. Kramer - filed by Chugai Pharmaceutical Co., Ltd.. (Keller, Karen) (Entered: 09/14/2017)
2017-09-14
1
SO ORDERED - re 22 MOTION for Pro Hac Vice Appearance of Attorney David C. Doyle and Brian M. Kramer filed by Chugai Pharmaceutical Co., Ltd.. Ordered by Judge Gregory M. Sleet on 9/15/2017. (mdb)
2017-09-15
1
No Actions
SO ORDERED
2017-09-15
1
No Actions
ORAL ORDER re 17 Joint Status Report - Because defendant Chugai Pharmaceutical Co., Ltd. did not participate in the telephone conference prior to submitting the joint status report, defendant Chugai shall file a letter indicating their positions on the contents of the joint status report and proposed schedule within seven days of this order. Ordered by Judge Gregory M. Sleet on 9/19/2017. (mdb)
2017-09-19
1
No Actions
Oral Order
2017-09-19
1
No Actions
Add Attorneys Pro Hac Vice
2017-09-20
1
No Actions
Add Attorneys - PHV only
2017-09-20
1
No Actions
Pro Hac Vice Attorney David C. Doyle and Brian M. Kramer for Chugai Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
2017-09-20
1
No Actions
Letter to The Honorable Gregory M. Sleet from David M. Fry. (Fry, David) (Entered: 09/26/2017)
2017-09-26
1
ANSWERING BRIEF in Opposition re 18 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 10/4/2017. (Connolly, Colm) (Entered: 09/27/2017)
2017-09-27
1
DECLARATION of Amanda S. Williamson re 24 Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb). (Entered: 09/27/2017)
2017-09-27
1
NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm) (Entered: 09/29/2017)
2017-09-29
1
NOTICE OF SERVICE of Defendant Genentech, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 09/29/2017)
2017-09-29
1
NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 10/02/2017)
2017-10-02
1
REPLY BRIEF re 18 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Chugai Pharmaceutical Co., Ltd.. (Keller, Karen) (Entered: 10/04/2017)
2017-10-04
1
ORAL ORDER re 17 Joint Status Report - The parties' proposed schedule is ADOPTED, with the following additions: The Markman Hearing (1/2 day) is set for 7/16/2018 at 9:30 AM in Courtroom 4A, the Final Pretrial Conference is set for 8/26/2019 at 10:00 AM in Courtroom 4A, and a 7-day Jury Trial is set for 9/9/2019 at 9:30 AM in Courtroom 4A. This case is referred to the Magistrate Judge for exploring ADR. The plaintiff shall file an amended scheduling order incorporating the full case schedule by 10/11/2017. Ordered by Judge Gregory M. Sleet on 10/4/2017. (mdb)
2017-10-04
1
No Actions
Oral Order
2017-10-04
1
No Actions
Letter to The Honorable Gregory M. Sleet from Colm F. Connolly regarding jointly submitting a scheduling order for the Court's consideration - re Oral Order,,. (Attachments: # 1 Text of Proposed Order - Scheduling Order)(Connolly, Colm) (Entered: 10/11/2017)
2017-10-11
1
SO ORDERED AND Scheduling Order - Patent
2017-10-12
1
No Actions
SO ORDERED
2017-10-12
1
No Actions
SO ORDERED - re 30 Scheduling Order: Case referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and Amended Pleadings due by 6/7/2018., Claim Construction Opening Briefs due by 5/11/2018., Claim Construction Answering Briefs due by 6/15/2018., A Markman Hearing (1/2 day) is set for 7/16/2018 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 8/31/2018., Opening Expert Reports due by 10/5/2018., Rebuttal Expert Reports due by 11/9/2018., Reply Expert Reports due by 12/7/2018., Expert Discovery due by 1/31/2019., Opening Summary Judgment Letter Briefs due by 2/14/2019., Answering Letter Briefs due 2/28/2019., Reply Letter Briefs due 3/7/2019., Proposed Pretrial Order due by 8/16/2019., A Final Pretrial Conference is set for 8/26/2019 at 10:00 AM in Courtroom 4A., and a 7-day Jury Trial is set for 9/9/2019 at 09:30 AM in Courtroom 4A. See Scheduling Order ( 30 ) for more details). Ordered by Judge Gregory M. Sleet on 10/12/2017. (mdb)
2017-10-12
1
No Actions
NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-107) filed by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm) (Entered: 10/17/2017)
2017-10-17
1
STIPULATION Seeking to Extend the Deadline by which the Parties Must Submit a Proposed Protective Order, by Genentech, Inc.. (Balick, Steven) (Entered: 10/23/2017)
2017-10-23
1
Case Referred to Mediation - Magistrate Judge only
2017-10-23
1
No Actions
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
2017-10-23
1
No Actions
Case Referred to Mediation
2017-10-23
1
No Actions
ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 11/30/2017 at 11:00 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 10/24/17. (cak) (Entered: 10/24/2017)
2017-10-24
1
SO ORDERED - re 32 Stipulation Seeking to Extend the Deadline by which the Parties Must Submit a Proposed Protective Order filed by Genentech, Inc.. Ordered by Judge Gregory M. Sleet on 10/26/2017. (mdb)
2017-10-26
1
No Actions
SO ORDERED
2017-10-26
1
No Actions
STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to November 9, 2017 - filed by Chugai Pharmaceutical Co., Ltd.. (Shaw, John) (Entered: 11/02/2017)
2017-11-02
1
NOTICE OF SERVICE of Genentech, Inc.'s First Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Mayo, Andrew) (Entered: 11/02/2017)
2017-11-02
1
SO ORDERED - re 34 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to November 9, 2017 filed by Chugai Pharmaceutical Co., Ltd.. Ordered by Judge Gregory M. Sleet on 11/2/2017. (mdb)
2017-11-02
1
No Actions
SO ORDERED
2017-11-02
1
No Actions
NOTICE OF SERVICE of Defendant Genentech, Inc.'s Initial Disclosures Pursuant to Section 3 of the Default Standard for Discovery filed by Genentech, Inc..(Balick, Steven) (Entered: 11/03/2017)
2017-11-03
1
NOTICE OF SERVICE of Chugai Pharmaceutical Co., Ltd.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 11/06/2017)
2017-11-06
1
PROPOSED ORDER - Stipulated Protective Order by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) (Entered: 11/09/2017)
2017-11-09
1
SO ORDERED - re 38 (Proposed) Stipulated Protective Order filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 11/13/2017. (mdb)
2017-11-13
1
No Actions
SO ORDERED
2017-11-13
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Initial Disclosure of Infringement Contentions Pursuant to October 11, 2017 Scheduling Order filed by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm) (Entered: 11/17/2017)
2017-11-17
1
NOTICE of Appearance by Amy Michele Dudash on behalf of All Plaintiffs (Dudash, Amy) (Entered: 12/12/2017)
2017-12-12
1
MOTION for Preliminary Injunction - filed by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) (Entered: 12/14/2017)
2017-12-14
1
[SEALED] MEMORANDUM in Support re 41 MOTION for Preliminary Injunction filed by Baxalta GmbH, Baxalta Incorporated.Answering Brief/Response due date per Local Rules is 12/28/2017. (Attachments: # 1 Text of Proposed Order)(Connolly, Colm) (Entered: 12/14/2017)
2017-12-14
1
[SEALED] DECLARATION re 42 MEMORANDUM in Support of Plaintiffs' Memorandum in Support of Their Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit Exhibits M, EE, JJ and PP that are Sealed)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
EXHIBIT A re 43 Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit F, # 6 Exhibit G, # 7 Exhibit H, # 8 Exhibit I, # 9 Exhibit J, # 10 Exhibit K, # 11 Exhibit L, # 12 Exhibit N, # 13 Exhibit O, # 14 Exhibit P, # 15 Exhibit Q, # 16 Exhibit R, # 17 Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
EXHIBIT T re 44 Exhibit to a Document, 43 Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit U, # 2 Exhibit V, # 3 Exhibit W, # 4 Exhibit X, # 5 Exhibit Y, # 6 Exhibit Z, # 7 Exhibit AA, # 8 Exhibit BB, # 9 Exhibit CC, # 10 Exhibit DD, # 11 Exhibit FF, # 12 Exhibit GG, # 13 Exhibit HH, # 14 Exhibit II, # 15 Exhibit KK, # 16 Exhibit LL, # 17 Exhibit MM, # 18 Exhibit NN, # 19 Exhibit OO, # 20 Exhibit QQ, # 21 Exhibit RR, # 22 Exhibit SS, # 23 Exhibit TT, # 24 Exhibit UU, # 25 Exhibit VV, # 26 Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
DECLARATION of Dr. Louis M. Aledort re 42 MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
DECLARATION of Krishnaswamy, Ph.D. re 42 MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit H, # 8 Exhibit I, # 9 Exhibit K, # 10 Exhibit L, # 11 Exhibit M, # 12 Exhibit N, # 13 Exhibit O, # 14 Exhibit P, # 15 Exhibit Q, # 16 Exhibit R, # 17 Exhibit S, # 18 Exhibit T, # 19 Exhibit U, # 20 Exhibit V, # 21 Exhibit W, # 22 Exhibit X, # 23 Exhibit Y, # 24 Exhibit Z, # 25 Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
DECLARATION of Anthony A. Kossiakoff, Ph.D. re 42 MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Exhibit X, # 25 Exhibit Y, # 26 Exhibit Z, # 27 Exhibit AA, # 28 Exhibit BB, # 29 Exhibit CC, # 30 Exhibit DD, # 31 Exhibit EE, # 32 Exhibit FF, # 33 Exhibit GG, # 34 Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
DECLARATION of Juan Carlos Almagro, Ph.D. re 42 MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb). (Entered: 12/14/2017)
2017-12-14
1
NOTICE OF SERVICE of Genetech's Preliminary Invalidity Contentions filed by Genentech, Inc..(Mayo, Andrew) (Entered: 12/15/2017)
2017-12-15
1
NOTICE of Appearance by Jody Barillare on behalf of All Plaintiffs (Barillare, Jody) (Entered: 12/18/2017)
2017-12-18
1
NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Preliminary Invalidity Contentions filed by Chugai Pharmaceutical Co., Ltd..(Fry, David) (Entered: 12/18/2017)
2017-12-18
1
NOTICE OF SERVICE of Genentech's Objections and Responses to Baxalta's First Set of Requests for Production filed by Genentech, Inc..(Mayo, Andrew) (Entered: 12/18/2017)
2017-12-18
1
Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 12/18/2017, (A Status Telephone Conference regarding the Motion for Preliminary Injunction ( 41 ) is set for Friday, December 22, 2017 at 3:00 PM. Counsel for plaintiffs shall arrange the call and contact Chambers at 302-573-4559 once all parties are on the line. (Court Reporter Kevin Maurer.) (mdb)
2017-12-18
1
No Actions
ORAL ORDER re 41 Motion for Preliminary Injunction - A Telephone Conference is set for today, December 18, 2017 at 2:00 PM (EST). The plaintiffs shall arrange the call and contact Chambers at 302-573-4559 once all parties are on the line. Ordered by Judge Gregory M. Sleet on 12/18/2017. (mdb)
2017-12-18
1
No Actions
Oral Order AND ~Util - Set Deadlines
2017-12-18
1
No Actions
Telephone Conference AND ~Util - Set Deadlines/Hearings
2017-12-18
1
No Actions
Telephone Conference
2017-12-18
1
No Actions
Oral Order
2017-12-18
1
No Actions
ORAL ORDER CANCELLING TELECONFERENCE: The Status Telephone Conference regarding 41 Motion for Preliminary Injunction previously set for Friday, December 22, 2017 at 3:00 PM is CANCELLED. The parties shall submit a Stipulation with a proposed schedule and include a date the parties are available to attend a hearing on the Motion for Preliminary Injunction. If the parties are unable to agree on a proposed schedule, the court shall set a Telephone Conference on Friday, January 5, 2018 at 10:00 AM. The parties shall contact chambers if a Teleconference is not necessary. Ordered by Judge Gregory M. Sleet on 12/19/2017. (asw)
2017-12-19
1
No Actions
Oral Order
2017-12-19
1
No Actions
NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-107) filed by Chugai Pharmaceutical Co., Ltd..(Fry, David) (Entered: 12/20/2017)
2017-12-20
1
Set/Reset Hearings: A Telephone Conference re: Motion for Preliminary Injunction is TENTATIVELY set for 1/5/2018 at 10:00 AM before Judge Gregory M. Sleet. (asw)
2017-12-20
1
No Actions
Add Attorneys - PHV only
2017-12-20
1
No Actions
Pro Hac Vice Attorney Michael J. Abernathy and Christopher J Betti for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-12-20
1
No Actions
Add Attorneys Pro Hac Vice
2017-12-20
1
No Actions
Set/Reset Hearings
2017-12-20
1
No Actions
REDACTED VERSION of 42 MEMORANDUM in Support of its Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) Modified on 12/21/2017 (mdb). (Entered: 12/21/2017)
2017-12-21
1
REDACTED VERSION of [Proposed] Preliminary Injunction Order by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) Modified on 12/21/2017 (mdb). (Entered: 12/21/2017)
2017-12-21
1
REDACTED VERSION of 43 Declaration of W. Christopher Bakewell Regarding Irreparable Harm and Balance of Hardships in Support of Plaintiffs' Memorandum in Support of Their Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Public Versions of Exhibits M, EE, JJ, and PP)(Connolly, Colm) Modified on 12/21/2017 (mdb). (Entered: 12/21/2017)
2017-12-21
1
REDACTED VERSION of 43 Declaration of W. Christopher Bakewell Regarding Irreparable Harm and Balance of Hardships in Support of Plaintiffs' Memorandum in Support of Their Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Public Versions of Exhibits M, EE, JJ, and PP)(Connolly, Colm) Modified on 12/21/2017 (mdb). (Entered: 12/21/2017)
2017-12-21
2
Official Transcript of Telephone Conference held on 12 18 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/12/2018. Redacted Transcript Deadline set for 1/22/2018. Release of Transcript Restriction set for 3/22/2018. (kjm) (Entered: 12/22/2017)
2017-12-22
1
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GMBH Responses and Objections to Genentech, Inc.'s First Set of Requests for the Production of Documents and Things filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/02/2018)
2018-01-02
1
Joint STIPULATION Regarding Scheduling for Plaintiffs' Motion for Preliminary Injunction re Oral Order,, Set/Reset Hearings by Baxalta Incorporated. (Dudash, Amy) (Entered: 01/04/2018)
2018-01-04
1
SO ORDERED - re 60 Stipulation and Proposed Scheduling Order re Motion for Preliminary Injunction ( 41 ): Answering Brief due 4/6/2018, Reply Brief due 4/24/2018, Oral Argument is set for 5/24/2018 at 09:00 AM in Courtroom 4A. See stipulation for more details. The January 5, 2018 telephone conference is CANCELLED. Signed by Judge Gregory M. Sleet on 1/5/20158. (mdb) (Entered: 01/05/2018)
2018-01-05
1
NOTICE OF SERVICE of Plaintiffs' First Set of Expedited Requests for Production of Documents and Things to Defendant (Nos. 1-13) Relating to the Motion for Preliminary Injunction filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/05/2018)
2018-01-05
1
NOTICE OF SERVICE of Genentech's Discovery Requests Related to Plaintiffs' Motion for a Preliminary Injunction filed by Genentech, Inc..(Mayo, Andrew) (Entered: 01/05/2018)
2018-01-05
1
ORAL ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 6/29/2018 at 11:00 AM Eastern Time before Judge Mary Pat Thynge to discuss the status of the case, the parties to be involved in mediation in March 2019 and submissions. Ordered by Judge Mary Pat Thynge on 1/9/18. (cak) (Entered: 01/09/2018)
2018-01-09
1
MOTION for Pro Hac Vice Appearance of Attorney Caroline S. Lourgos - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/09/2018)
2018-01-09
1
Order Setting Teleconference
2018-01-09
1
No Actions
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH Responses and Objections to Genentech, Inc.'s Discovery Requests Related to Plaintiffs' Motion for a Preliminary Injunction filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/10/2018)
2018-01-10
1
NOTICE OF SERVICE of Genentech's Objections and Responses to Plaintiffs' Expedited Requests for Production filed by Genentech, Inc..(Balick, Steven) (Entered: 01/10/2018)
2018-01-10
1
Pro Hac Vice Attorney Caroline Lourgos for Baxalta GmbH,Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-01-10
1
No Actions
SO ORDERED - re 65 MOTION for Pro Hac Vice Appearance of Attorney Caroline S. Lourgos filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 1/10/2018. (mdb)
2018-01-10
1
No Actions
Add Attorneys - PHV only
2018-01-10
1
No Actions
Add Attorneys Pro Hac Vice
2018-01-10
1
No Actions
SO ORDERED
2018-01-10
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Sanjay K. Murthy - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/12/2018)
2018-01-12
1
SO ORDERED - re 68 MOTION for Pro Hac Vice Appearance of Attorney Sanjay K. Murthy filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 1/16/2018. (mdb)
2018-01-16
1
No Actions
SO ORDERED
2018-01-16
1
No Actions
NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (1-20) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/17/2018)
2018-01-17
1
Pro Hac Vice Attorney Sanjay K. Murthy for Baxalta GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
2018-01-17
1
No Actions
Add Attorneys - PHV only
2018-01-17
1
No Actions
Add Attorneys Pro Hac Vice
2018-01-17
1
No Actions
NOTICE OF SERVICE of Plaintiffs' List of Claim Terms in Need of Construction filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/19/2018)
2018-01-19
1
NOTICE to Take Deposition of Genentech, Inc. and Chugai Pharmaceutical Co., Ltd. on mutually agreeable date in accordance with the scheduling order filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/19/2018)
2018-01-19
1
NOTICE OF SERVICE of Genentech's Identification of Claim Terms that Need to be Construed filed by Genentech, Inc..(Mayo, Andrew) (Entered: 01/19/2018)
2018-01-19
1
NOTICE OF SERVICE of (1) Chugai Pharmaceutical Co., Ltd.'s Identification of Claim Terms that Need to be Construed filed by Chugai Pharmaceutical Co., Ltd..(Fry, David) (Entered: 01/22/2018)
2018-01-22
1
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH's Supplemental Responses and Objections to Genetech, Inc.'s Interrogatories Nos. 1-2 and Requests for Admission Nos. 3, 4, 7 and 8 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/31/2018)
2018-01-31
1
MOTION for Pro Hac Vice Appearance of Attorney Jesse T. Dyer - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 02/06/2018)
2018-02-06
1
NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoenas to Kilpatrick Townsend & Stockton LLP filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/06/2018)
2018-02-06
1
ORAL ORDER - A Discovery Dispute Telephone Conference (#1) is set for Monday, February 12, 2018 at 10:00 AM (EST). Counsel for the plaintiffs shall arrange the call and contact Chambers at 302-573-4559 once all parties are on the line. A non-argumentative Joint Agenda Letter (see www.ded.uscourts.gov for an example) is due by noon on Thursday, February 8, 2018. Ordered by Judge Gregory M. Sleet on 2/6/2018. (mdb)
2018-02-06
1
No Actions
Oral Order AND ~Util - Set Deadlines/Hearings
2018-02-06
1
No Actions
Oral Order
2018-02-06
1
No Actions
NOTICE OF SERVICE of Genentech, Inc.'s Second Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH (Nos. 99-101) and Genentech, Inc.'s First Set of Interrogatories (Nos. 3-11) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/07/2018)
2018-02-07
1
SO ORDERED - re 75 MOTION for Pro Hac Vice Appearance of Attorney Jesse T. Dyer filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 2/7/2018. (mdb)
2018-02-07
1
No Actions
SO ORDERED
2018-02-07
1
No Actions
NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoena to Haematologic Technologies, Inc. filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/08/2018)
2018-02-08
1
Letter to The Honorable Gregory M. Sleet from Steven J. Balick regarding the Parties' Joint Agenda for the Teleconference on February 12, 2018 at 10:00 a.m.. (Balick, Steven) (Entered: 02/08/2018)
2018-02-08
1
NOTICE OF SERVICE of Notice of Subpoenas to Thomas A. Larmondra filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/08/2018)
2018-02-08
1
MOTION for Pro Hac Vice Appearance of Attorney Stephen D. Keane - filed by Chugai Pharmaceutical Co., Ltd.. (Keller, Karen) (Entered: 02/08/2018)
2018-02-08
1
Pro Hac Vice Attorney Jesse T. Dyer for Baxalta GmbH,Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-02-08
1
No Actions
Add Attorneys - PHV only
2018-02-08
1
No Actions
Add Attorneys Pro Hac Vice
2018-02-08
1
No Actions
NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoenas to Shire LLC filed by Genentech, Inc..(Balick, Steven) (Entered: 02/09/2018)
2018-02-09
1
NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoenas to Shire US Inc. filed by Genentech, Inc..(Balick, Steven) (Entered: 02/09/2018)
2018-02-09
1
SO ORDERED - re 81 MOTION for Pro Hac Vice Appearance of Attorney Stephen D. Keane filed by Chugai Pharmaceutical Co., Ltd. Ordered by Judge Gregory M. Sleet on 2/9/2018. (mdb)
2018-02-09
1
No Actions
SO ORDERED
2018-02-09
1
No Actions
Pro Hac Vice Attorney Stephen D. Keane for Chugai Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
2018-02-12
1
No Actions
Set/Reset Hearings: An Oral Argument (2 days) re 41 Motion for Preliminary Injunction is set for 6/13/2018 at 9:30 AM in Courtroom 4A before Judge Gregory M. Sleet. (mdb)
2018-02-12
1
No Actions
Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 2/12/2018. Discussion on the disputed item listed in the Joint Agenda submission; extending the briefing schedule regarding the preliminary injunction and amending the schedule. The court will set a 2-day Hearing Re: Preliminary Injunction on 6/13/2018 at 9:30 AM through 6/14/2018. The court ordered the parties to file an Amended Scheduling Order as discussed during the Teleconference. (Court Reporter: Kevin Maurer.) (asw)
2018-02-12
1
No Actions
Add Attorneys - PHV only
2018-02-12
1
No Actions
Add Attorneys Pro Hac Vice
2018-02-12
1
No Actions
Set/Reset Hearings
2018-02-12
1
No Actions
Telephone Conference
2018-02-12
1
No Actions
NOTICE OF SERVICE of Genentech, Inc.'s Objections and Responses to Baxalta's First Set of Interrogatories (Nos. 1-20) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/16/2018)
2018-02-16
1
NOTICE OF SERVICE of (1) Defendant Chugai Pharmaceutical Co., Ltd.'s Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-20) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 02/19/2018)
2018-02-19
1
Official Transcript of Teleconference held on 2/12/18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/16/2018. Redacted Transcript Deadline set for 3/26/2018. Release of Transcript Restriction set for 5/24/2018. (kjm) (Entered: 02/23/2018)
2018-02-23
1
NOTICE OF SERVICE of Defendant Genentech, Inc.'s Preliminary Identification of Claim Terms and Proposed Constructions filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/23/2018)
2018-02-23
1
NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 02/23/2018)
2018-02-23
1
NOTICE OF SERVICE of (1) Defendant Chugai Pharmaceutical Co., Ltd.'s Preliminary Identification of Claim Terms and Proposed Constructions filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 02/26/2018)
2018-02-26
1
NOTICE OF SERVICE of Defendant Genentech's Notice of Deposition of Plaintiffs Baxalta Incorporated and Baxalta GmbH Related to Plaintiffs' Motion for Preliminary Injunction filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/28/2018)
2018-02-28
1
Case Reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
2018-02-28
1
No Actions
Case Assigned/Reassigned
2018-02-28
1
No Actions
NOTICE OF SERVICE of Non-Parties Shire LLC, Shire US, Inc., and Thomas A. Larmondra's Objections and Responses to Genentech, Inc.'s Subpoenas re 83 Notice of Service, 80 Notice of Service, 82 Notice of Service filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 03/01/2018)
2018-03-01
1
MOTION for Pro Hac Vice Appearance of Attorney James V. Razick - filed by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/02/2018)
2018-03-02
1
Joint STIPULATION Regarding Revised Schedule for Plaintiffs' Motion for Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/02/2018)
2018-03-02
1
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH's Responses and Objections to Genentech's Notice of Deposition re 90 Notice of Service filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 03/05/2018)
2018-03-05
1
SO ORDERED, re 92 MOTION for Pro Hac Vice Appearance of Attorney James V. Razick filed by Genentech, Inc. Signed by Judge Leonard P. Stark on 3/5/18. (ntl)
2018-03-05
1
No Actions
SO ORDERED
2018-03-05
1
No Actions
SO ORDERED, re 93 Amended Stipulation and Scheduling Order -- the Markman Hearing is rescheduled for 8/2/2018 at 10:00 AM in Courtroom 6B. Signed by Judge Leonard P. Stark on 3/9/18. (ntl) (Entered: 03/09/2018)
2018-03-09
1
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH Responses and Objections to Genentech, Inc.'s Second Set of Interrogatories and Baxalta Incorporated and Baxalta GmbH's Responses and Objections to Genentech, Inc.'s Second Set of Requests for the Production of Documents and Things filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 03/09/2018)
2018-03-09
1
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH's First Set of Requests for Admission to Chugai Pharmaceutical Co., Ltd. (Nos. 1-6) and Baxalta Incorporated and Baxalta GmbH's First Set of Requests for Admission to Genentech, Inc. (Nos. 1-3) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 03/23/2018)
2018-03-23
1
DECLARATION of Gallia Levy, M.D., Ph.D. in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
DECLARATION of Harvey Liverman in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
[SEALED] DECLARATION of Gina Chapman in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
REDACTED VERSION of 100 Declaration of Gina Chapman in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
[SEALED] DECLARATION of Greg Hogan in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
REDACTED VERSION of 102 Declaration of Greg Hogan in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
[SEALED] DECLARATION of Chelsey Serrano in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
REDACTED VERSION of 104 Declaration of Chelsey Serrano in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/23/2018)
2018-03-23
1
NOTICE of Asserted Claim In Baxalta's Opening Memorandum In Support of Its Motion for a Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated re 42 MEMORANDUM in Support, (Dudash, Amy) (Entered: 03/29/2018)
2018-03-29
1
Amended EXHIBIT re 46 Declaration, Amended Exhibit B to Declaration of Dr. Aledort by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 03/29/2018)
2018-03-29
1
[SEALED] DECLARATION of Jerry A. Hausman, Ph.D. in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/30/2018)
2018-03-30
1
[SEALED] DECLARATION of Michael U. Callaghan, M.D. In Support of Genentech, Inc.'s Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/30/2018)
2018-03-30
1
[SEALED] DECLARATION of Guy A. Young, M.D. in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew) (Entered: 03/30/2018)
2018-03-30
1
[SEALED] DECLARATION of John P. Sheehan, M.D. in Support of Genentech's Opposition to Baxalta's Motion for a Preliminary Injunction by Genentech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Exhibit X, # 25 Exhibit Y, # 26 Exhibit Z, # 27 Exhibit AA, # 28 Exhibit BB, # 29 Exhibit CC, # 30 Exhibit DD, # 31 Exhibit EE, # 32 Exhibit FF, # 33 Exhibit GG, # 34 Exhibit HH, # 35 Exhibit II, # 36 Exhibit JJ, # 37 Exhibit KK)(Mayo, Andrew) (Entered: 03/30/2018)
2018-03-30
1
[SEALED] DECLARATION of William R. Strohl, Ph.D. in Support of Genentech, Inc.'s Opposition to Baxalta's Motion for a Preliminary Injunction by Genentech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Exhibit X, # 25 Exhibit Y, # 26 Exhibit Z, # 27 Exhibit AA, # 28 Exhibit BB, # 29 Exhibit CC, # 30 Exhibit DD, # 31 Exhibit EE, # 32 Exhibit FF, # 33 Exhibit GG, # 34 Exhibit HH, # 35 Exhibit II, # 36 Exhibit JJ, # 37 Exhibit KK, # 38 Exhibit LL, # 39 Exhibit MM, # 40 Exhibit NN, # 41 Exhibit OO, # 42 Exhibit PP, # 43 Exhibit QQ, # 44 Exhibit RR, # 45 Exhibit SS, # 46 Exhibit TT, # 47 Exhibit UU, # 48 Exhibit VV, # 49 Exhibit WW, # 50 Exhibit XX, # 51 Exhibit YY, # 52 Exhibit ZZ, # 53 Exhibit AAA, # 54 Exhibit BBB, # 55 Exhibit CCC, # 56 Exhibit DDD, # 57 Exhibit EEE, # 58 Exhibit FFF, # 59 Exhibit GGG, # 60 Exhibit HHH, # 61 Exhibit III, # 62 Exhibit JJJ, # 63 Exhibit KKK, # 64 Exhibit LLL, # 65 Exhibit MMM, # 66 Exhibit NNN, # 67 Exhibit OOO, # 68 Exhibit PPP, # 69 Exhibit QQQ, # 70 Exhibit RRR, # 71 Exhibit SSS, # 72 Exhibit TTT, # 73 Exhibit UUU, # 74 Exhibit VVV, # 75 Exhibit WWW, # 76 Exhibit XXX, # 77 Exhibit YYY, # 78 Exhibit ZZZ, # 79 Exhibit AAAA, # 80 Exhibit BBBB)(Mayo, Andrew) (Entered: 03/30/2018)
2018-03-30
1
NOTICE OF SERVICE of Chugai Pharmaceutical Co., Ltd.'s First Amended Preliminary Identification of Claim Terms that Need to be Construed filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 04/03/2018)
2018-04-03
1
NOTICE to Take Deposition of Gallia Levy on April 5, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/04/2018)
2018-04-04
1
NOTICE to Take Deposition of Gina Chapman on April 6, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/04/2018)
2018-04-04
1
REDACTED VERSION of 108 Declaration (of Jerry A. Hausman, Ph.D.) by Genentech, Inc.. (Mayo, Andrew) (Entered: 04/06/2018)
2018-04-06
1
REDACTED VERSION of 109 Declaration (of Michael U. Callaghan, M.D.) by Genentech, Inc.. (Mayo, Andrew) (Entered: 04/06/2018)
2018-04-06
1
REDACTED VERSION of 110 Declaration (of Guy A. Young, M.D.) by Genentech, Inc.. (Mayo, Andrew) (Entered: 04/06/2018)
2018-04-06
1
REDACTED VERSION of 111 Declaration,,, (of John P. Sheehan, M.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit A-Z, # 2 Exhibit AA-KK)(Mayo, Andrew) (Entered: 04/06/2018)
2018-04-06
1
REDACTED VERSION of 112 Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit A-K, # 2 Exhibit L-Z, # 3 Exhibit AA-LL, # 4 Exhibit MM-GGG, # 5 Exhibit HHH-SSS, # 6 Exhibit TTT-BBBB)(Mayo, Andrew) (Entered: 04/06/2018)
2018-04-06
1
NOTICE to Take Deposition of Gallia Levy (REVISED) on April 5, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/06/2018)
2018-04-06
1
NOTICE to Take Deposition of Gina Chapman (REVISED) on April 6, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/06/2018)
2018-04-06
1
CLAIM Construction Chart by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 04/06/2018)
2018-04-06
1
DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Exhibit 12, # 10 Exhibit 13, # 11 Exhibit 14, # 12 Exhibit 15, # 13 Exhibit 16, # 14 Exhibit 17, # 15 Exhibit 18, # 16 Exhibit 19, # 17 Exhibit 20, # 18 Exhibit 21, # 19 Exhibit 22, # 20 Exhibit 23, # 21 Exhibit 24, # 22 Exhibit 25)(Dudash, Amy) (Entered: 04/11/2018)
2018-04-11
1
[SEALED] EXHIBIT re 124 Declaration,, Exhibits 5, 6, and 7 to Rebuttal Declaration of Juan Carlos Almagro, PhD., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 04/11/2018)
2018-04-11
1
[SEALED] DECLARATION by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 27, # 26 Exhibit 28, # 27 Exhibit 29, # 28 Exhibit 30, # 29 Exhibit 31, # 30 Exhibit 32, # 31 Exhibit 33, # 32 Exhibit 34, # 33 Exhibit 35, # 34 Exhibit 36, # 35 Exhibit 37, # 36 Exhibit 38, # 37 Exhibit 39, # 38 Exhibit 40)(Dudash, Amy) Modified on 4/12/2018 (etg). (Entered: 04/11/2018)
2018-04-11
1
[SEALED] EXHIBIT re 126 Declaration,,, Exhibits 25 and 26 to Rebuttal Declaration of Anthony A. Kossiakoff, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 04/11/2018)
2018-04-11
1
[SEALED] DECLARATION of Sriram Krishnaswamy in Support of Plaintiff's Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 5, # 2 Exhibit 7)(Dudash, Amy) (Entered: 04/11/2018)
2018-04-11
1
EXHIBIT re 128 Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 6, # 5 Exhibit 8)(Dudash, Amy) (Entered: 04/11/2018)
2018-04-11
1
[SEALED] Amended EXHIBIT re 126 Declaration,,, 127 Exhibit to a Document, Exhibit 26 to Rebuttal Declaration of Anthony A. Kossiakoff, PhD, in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 04/12/2018)
2018-04-12
1
- CORRECTING ENTRY
2018-04-12
1
No Actions
CORRECTING ENTRY: As per the request of counsel, D.I. 126 has been placed under seal. (etg)
2018-04-12
1
No Actions
CORRECTING ENTRY:
2018-04-12
1
No Actions
AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. Amendment to 123 Claim Construction Chart . (Dudash, Amy) (Entered: 04/16/2018)
2018-04-16
1
NOTICE to Take Deposition of Guy Young on April 25, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/16/2018)
2018-04-16
1
NOTICE to Take Deposition of Jerry Hausman on April 18, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/16/2018)
2018-04-16
1
NOTICE to Take Deposition of Michael Callaghan on April 20, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/16/2018)
2018-04-16
1
NOTICE to Take Deposition of William Strohl on April 18, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/16/2018)
2018-04-16
1
NOTICE to Take Deposition of John Sheehan on April 23, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 04/16/2018)
2018-04-16
1
MOTION for Pro Hac Vice Appearance of Attorney Jason C. White - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 04/17/2018)
2018-04-17
1
SEALED DECLARATION re 126 Declaration,,, of Anthony Kossiakoff by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 25 - REDACTED, # 2 Exhibit 26 - REDACTED)(Dudash, Amy) (Entered: 04/18/2018)
2018-04-18
1
DECLARATION re 128 Declaration of Sriram Krishnaswamy - REDACTED by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 5 - REDACTED, # 2 Exhibit 7 - REDACTED)(Dudash, Amy) (Entered: 04/18/2018)
2018-04-18
1
SO ORDERED, re 137 MOTION for Pro Hac Vice Appearance of Attorney Jason C. White filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Leonard P. Stark on 4/19/18. (ntl)
2018-04-19
1
No Actions
SO ORDERED
2018-04-19
1
No Actions
NOTICE OF SERVICE of (1) Defendant Chugai Pharmaceutical Co., Ltd.'s Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-3) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 04/23/2018)
2018-04-23
1
NOTICE OF SERVICE of Genentech's Objections and Responses to Baxalta's First Set of Requests for Admission filed by Genentech, Inc..(Mayo, Andrew) (Entered: 04/23/2018)
2018-04-23
1
NOTICE to Take Deposition of Juan Carlos Almagro, Ph.D. on April 26, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 04/24/2018)
2018-04-24
1
NOTICE OF SERVICE of Defendant Genentech, Inc.'s Amended Initial Disclosures Pursuant to Section 3 of the Default Standard for Discovery filed by Genentech, Inc..(Balick, Steven) (Entered: 04/26/2018)
2018-04-26
1
Pro Hac Vice Attorney Jason C. White for Baxalta GmbH, Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-04-26
1
No Actions
Add Attorneys Pro Hac Vice
2018-04-26
1
No Actions
NOTICE to Take Deposition of W. Christopher Bakewell on May 2, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 04/30/2018)
2018-04-30
1
NOTICE to Take Deposition of Sriram Krishnaswamy, Ph.D. on May 3, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 04/30/2018)
2018-04-30
1
NOTICE to Take Deposition of Louis M. Aledort, M.D. on May 4, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 04/30/2018)
2018-04-30
1
STIPULATION Seeking to Revise the Markman Briefing Schedule, by Genentech, Inc.. (Balick, Steven) (Entered: 05/02/2018)
2018-05-02
1
Case Reassigned to Judge Timothy Belcher Dyk of the U.S. Court of Appeals for Federal Circuit. Please include the initials of the Judge (TBD) after the case number on all documents filed. (rjb)
2018-05-04
1
No Actions
Case Assigned/Reassigned
2018-05-04
1
No Actions
NOTICE to Take Deposition of Anthony A. Kossiakoff, Ph.D. on May 10, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 05/08/2018)
2018-05-08
1
STIPULATION Requesting Additional Pages for Preliminary Injunction Answering and Reply Briefs, by Genentech, Inc.. (Balick, Steven) (Entered: 05/09/2018)
2018-05-09
1
ORAL ORDER: Status conference to be held at 2:00 p.m., Monday, May 14, 2018, in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. The parties should be prepared to discuss the following at the status conference: resetting the date for the Markman hearing and for trial and what if any claim-construction issues will need to be addressed as part of the preliminary-injunction proceedings. The deadlines for Markman briefing are extended as stipulated at ECF No. 147 to May 18, 2018, for the opening briefs and to July 2, 2018, for the responsive briefs. Ordered by Judge Timothy B. Dyk on 5/9/2018. (nmg)
2018-05-09
1
No Actions
Oral Order
2018-05-09
1
No Actions
ORDER: Going forward, the parties shall provide two copies of all filings made on the docket in this action to the following address:Chambers of Hon. Timothy B. Dyk, United States Court of Appeals for the Federal Circuit, 717 Madison Place N.W., Washington, DC 20439. Signed by Judge Timothy Belcher Dyk on 5/11/2018. (fms) (Entered: 05/11/2018)
2018-05-11
1
ORDER approving 149 Stipulation Requesting Additional Pages for Preliminary Injunction Answering and Reply Briefs. Signed by Judge Timothy Belcher Dyk on 5/11/2018. (fms) (Entered: 05/11/2018)
2018-05-11
1
Status Conference
2018-05-14
1
No Actions
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Status Conference held on 5/14/2018. The Markman Hearing set for 8/2/2018 is rescheduled for 9/13/2018 at 10:00 AM at the U.S. Court of Appeals for the Federal Circuit, Washington, DC. The parties will submit additional proposed revisions to the schedule by Friday, May 18, 2018. (Court Reporter present.) (crb)
2018-05-14
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Julie S. Goldemberg - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 05/15/2018)
2018-05-15
1
[SEALED] DECLARATION of David E. Cole in Support of Genentech's Memorandum of Law in Opposition to Plaintiff's Motion for a Preliminary Injunction, by Genentech, Inc.. (Attachments: # 1 Exhibit 1-25)(Balick, Steven) (Entered: 05/15/2018)
2018-05-15
1
[SEALED] ANSWERING BRIEF in Opposition re 41 MOTION for Preliminary Injunction, filed by Genentech, Inc..Reply Brief due date per Local Rules is 5/22/2018. (Balick, Steven) (Entered: 05/15/2018)
2018-05-15
1
Official Transcript of Status Conference held on 5/14/2018 before Judge Dyk. Court Reporter/Transcriber Keith A. Wilkerson, 1-800-211-3376. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 6/6/2018. Redacted Transcript Deadline set for 6/18/2018. Release of Transcript Restriction set for 8/14/2018. (nmf) (Entered: 05/17/2018)
2018-05-16
1
ORDER granting 152 MOTION for Pro Hac Vice Appearance of Attorney Julie S. Goldemberg filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 5/18/2018. (fms) (Entered: 05/18/2018)
2018-05-18
1
STIPULATION Seeking to Modify Scheduling Order, by Genentech, Inc.. (Balick, Steven) (Entered: 05/18/2018)
2018-05-18
1
CLAIM CONSTRUCTION OPENING BRIEF filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 05/18/2018)
2018-05-18
1
DECLARATION re 158 Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Dudash, Amy) (Entered: 05/18/2018)
2018-05-18
1
[SEALED] CLAIM CONSTRUCTION OPENING BRIEF filed by Genentech, Inc.. (Balick, Steven) (Entered: 05/18/2018)
2018-05-18
1
[SEALED] DECLARATION re 160 Claim Construction Opening Brief (Declaration of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit A-J)(Balick, Steven) (Entered: 05/18/2018)
2018-05-18
1
[SEALED] DECLARATION re 160 Claim Construction Opening Brief (Declaration of David E. Cole) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-3)(Balick, Steven) (Entered: 05/18/2018)
2018-05-18
1
[SEALED] DECLARATION re 160 Claim Construction Opening Brief (Declaration of John P. Sheehan, M.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit A-H)(Balick, Steven) (Entered: 05/18/2018)
2018-05-18
1
JOINDER by Chugai Pharmaceutical Co., Ltd., joining in 160 Claim Construction Opening Brief . (Keller, Karen) (Entered: 05/18/2018)
2018-05-18
1
SCHEDULING ORDER: The parties shall file any comments by joint letter, not to exceed five double-spaced pages, by May 21, 2018, by 6:00 p.m. ( Joinder of Parties due by 6/7/2018., Amended Pleadings due by 6/7/2018., Fact Discovery completed by 10/5/2018., Opening Expert Reports due by 11/9/2018., Rebuttal Expert Reports due by 12/14/2018., Expert Discovery due by 2/15/2019., Reply expert reports shall be served on or before January 11, 2019. A two-day Motion Hearing on the motion for a preliminary injunction is set for 6/13/2018 at 09:30 AM in Courtroom 4A before Judge Timothy Belcher Dyk of the U.S. District Court for the District of Delaware, Wilmington, DE., AN Oral Argument on the motion to dismiss is set for 6/12/2018 at 03:30 PM before Judge Timothy Belcher Dyk at the U.S. District Court for the District of Delaware, Wilmington, DE., Claim Construction Answering Brief due by 7/2/2018., A half-day Markman Hearing is set for 9/13/2018 at 10:00 AM before Judge Timothy Belcher Dyk at the U.S. Court of Appeals for the Federal Circuit, Washington, DC.), Set Briefing Schedule: re 41 MOTION for Preliminary Injunction (Reply Brief due 5/25/2018.). Any party seeking leave to file a dispositive motion shall file a letter brief, not to exceed five double-spaced pages, by March 1, 2019. Date for trial to be scheduled at a later date. (See order for further details and deadlines). Signed by Judge Timothy Belcher Dyk on 5/18/2018. (fms) (Entered: 05/21/2018)
2018-05-21
1
AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. - Second Amended Joint Claim Construction Chart for '590 Patent. (Dudash, Amy) (Entered: 05/21/2018)
2018-05-21
1
Letter to Honorable Timothy B. Dyk from Baxalta Incorporated, Baxalta GmbH and Chugai Pharmaceutical Co., Ltd. regarding May 18, 2018 Proposed Order Modifying Schedule - re 165 Scheduling Order,,,,,, Set Briefing Schedule,,,,,. (Dudash, Amy) (Entered: 05/21/2018)
2018-05-21
1
REDACTED VERSION of 153 Declaration of David E. Cole by Genentech, Inc.. (Attachments: # 1 Exhibit 1-25)(Mayo, Andrew) (Entered: 05/22/2018)
2018-05-22
1
REDACTED VERSION of 154 Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew) (Entered: 05/22/2018)
2018-05-22
1
MOTION for Pro Hac Vice Appearance of Attorney Karon N. Fowler - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 05/22/2018)
2018-05-22
1
ORDER granting 170 MOTION for Pro Hac Vice Appearance of Attorney Karon N. Fowler filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 5/22/2018. (fms) (Entered: 05/22/2018)
2018-05-22
1
NOTICE of Supplemental Developments Regarding Baxalta's Motion for a Preliminary Injunction, by Genentech, Inc. re 154 Answering Brief in Opposition (Balick, Steven) (Entered: 05/22/2018)
2018-05-22
1
DECLARATION re 154 Answering Brief in Opposition (Supplemental Declaration of David E. Cole in Support of Genentech's Opposition to Plaintiffs' Motion for a Preliminary Injunction), by Genentech, Inc.. (Attachments: # 1 Exhibit 26-28)(Balick, Steven) (Entered: 05/22/2018)
2018-05-22
1
ORAL ORDER: A teleconference has been set in this matter for Wednesday, May 23, 2018, at 4:00 PM. Counsel for plaintiffs shall initiate the call to chambers once all participants are on the line. Ordered by Judge Timothy B. Dyk on 5/22/2018.
2018-05-22
1
No Actions
Oral Order
2018-05-22
1
No Actions
ORDER MODIFYING SCHEDULE : All jurisdictional discovery for purposes of Defendant Chugai's pending motion to dismiss shall be completed by May 23, 2018. Set Briefing Schedule: re 41 MOTION for Preliminary Injunction (Reply Brief due 5/25/2018.) Joinder of Parties due by 6/7/2018. Amended Pleadings due by 6/7/2018. Fact Discovery completed by 10/5/2018. Expert Discovery due by 2/15/2019. A Motion Hearing is set for 6/13/2018 at 09:30 AM in Courtroom 4A at the U.S. District Court for the District of Delaware, Wilmington, DE before Judge Timothy Belcher Dyk An Oral Argument is set for 6/12/2018 at 03:30 PM in Courtroom 4A at the U.S. District Court for the District of Delaware, Wilmington, DE before Judge Timothy Belcher Dyk. Claim Construction Answering Brief due by 7/2/2018. A Markman Hearing is set for 9/13/2018 at 10:00 AM before Judge Timothy Belcher Dyk at the U.S. Court of Appeals for the Federal Circuit, Washington DC. Any party seeking leave to file a dispositive motion shall file a letter brief, not to exceed five double-spaced pages, by March 1, 2019. Date for trial to be scheduled at a later date. (See order for further details and deadlines). Signed by Judge Timothy Belcher Dyk on 5/23/18. (sar) (Entered: 05/24/2018)
2018-05-23
1
Pro Hac Vice Attorney Karon N. Fowler for Baxalta GmbH, Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-05-23
1
No Actions
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Telephone Conference held on 5/23/2018. (Court Reporter present.) (sar)
2018-05-23
1
No Actions
Telephone Conference
2018-05-23
1
No Actions
Add Attorneys Pro Hac Vice
2018-05-23
1
No Actions
NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Supplemental Responses to Plaintiffs' First Set of Interrogatories (Nos. 6-7) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen) (Entered: 05/24/2018)
2018-05-24
1
REDACTED VERSION of 160 Claim Construction Opening Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 05/25/2018)
2018-05-25
1
REDACTED VERSION of 161 Declaration of William R. Strohl, Ph.D. by Genentech, Inc.. (Attachments: # 1 Exhibit A-J)(Mayo, Andrew) (Entered: 05/25/2018)
2018-05-25
1
REDACTED VERSION of 162 Declaration of David E. Cole by Genentech, Inc.. (Attachments: # 1 Exhibit 1-3)(Mayo, Andrew) (Entered: 05/25/2018)
2018-05-25
1
REDACTED VERSION of 163 Declaration of John P. Sheehan, M.D. by Genentech, Inc.. (Attachments: # 1 Exhibit A-H)(Mayo, Andrew) (Entered: 05/25/2018)
2018-05-25
1
[SEALED] REPLY to Response to Motion re 41 MOTION for Preliminary Injunction filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit Amy Dudash, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Exhibit X, # 26 Exhibit Y, # 27 Exhibit Z, # 28 Exhibit AA, # 29 Exhibit BB, # 30 Exhibit CC, # 31 Exhibit DD, # 32 Exhibit EE, # 33 Exhibit FF, # 34 Exhibit GG, # 35 Exhibit HH, # 36 Exhibit II, # 37 Exhibit JJ)(Dudash, Amy) (Entered: 05/25/2018)
2018-05-25
1
CERTIFICATE OF SERVICE of Baxalta's Sealed Reply in Support of Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated re 180 Reply to Response to Motion,,, (Dudash, Amy) (Entered: 05/25/2018)
2018-05-25
1
MOTION for Leave to permit Patients for Access to Advanced Hemophilia Therapy to File an Amicus Brief - filed by Patients for Access to Advanced Hemophilia Therapy. (Attachments: # 1 Proposed Amicus Curiae Brief in Opposition to Plaintiff's Motion for a Preliminary Injunction)(nmf) (Entered: 05/30/2018)
2018-05-29
1
ORDER re 182 MOTION for Leave to permit to File an Amicus Brief filed by Patients for Access to Advanced Hemophilia Therapy. No later than June 6, 2018, Plaintiffs shall file a letter, not to exceed one page, containing any objections to the filing of the proposed amicus brief. Signed by Judge Timothy Belcher Dyk on 5/30/2018. (fms) (Entered: 05/30/2018)
2018-05-30
1
Official Transcript of Telephone Conference held on 5/23/2018 before Judge Timothy Belcher Dyk. Court Reporter/Transcriber Cynthia J. Conforti, CSR, CRR, Telephone number 800.211.3376. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/20/2018. Redacted Transcript Deadline set for 7/2/2018. Release of Transcript Restriction set for 8/28/2018. (fms) (Entered: 05/30/2018)
2018-05-30
1
ORDER denying the request to conduct a Rule 30(b)(6) deposition of Chugai on jurisdictional matters. See order for further details. Signed by Judge Timothy Belcher Dyk on 5/30/2018. (nmf) (Entered: 05/31/2018)
2018-05-30
1
REDACTED VERSION of 180 Reply to Response to Motion,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit Amy Dudash, # 2 Exhibit A-JJ)(Dudash, Amy) (Entered: 06/01/2018)
2018-06-01
1
REDACTED VERSION of 180 Reply to Response to Motion,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit Amy Dudash, # 2 Exhibit A-JJ)(Dudash, Amy) (Entered: 06/01/2018)
2018-06-01
2
REDACTED VERSION of 180 Reply to Response to Motion,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit Amy Dudash, # 2 Exhibit A-JJ)(Dudash, Amy) (Entered: 06/01/2018)
2018-06-01
2
[SEALED] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Motion to Dismiss - re 18 MOTION to Dismiss for Lack of Jurisdiction Over the Person . (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T)(Dudash, Amy) (Entered: 06/05/2018)
2018-06-05
1
CERTIFICATE OF SERVICE of Letter to The Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated re 187 Letter,, (Dudash, Amy) (Entered: 06/05/2018)
2018-06-05
1
Letter to The Honorable Timothy B. Dyk from Amy M. Dudash regarding plaintiff's submission of objections to Patents for Access to Advanced Hemophilia Therapy's ("PAAHT") Motion (D.I. 182) - re 183 Order, 182 MOTION for Leave to permit to File an Amicus Brief. (Dudash, Amy) (Entered: 06/06/2018)
2018-06-06
1
Oral Order
2018-06-06
1
No Actions
ORAL ORDER: The parties have raised a dispute concerning a privilege issue. No later than 5:00 PM on June 8, 2018, the parties shall file simultaneous letter briefs on this issue no longer than five double-spaced pages each. Ordered by Judge Timothy B. Dyk on 6/6/2018. (nmg)
2018-06-06
1
No Actions
Amicus Curiae Answering Brief in Opposition to D.I. 41 MOTION for Preliminary Injunction filed by Patients for Access to Advanced Hemophilia Therapy. Modified on 6/7/2018 (nmg). (Entered: 06/07/2018)
2018-06-07
1
[SEALED] Amended EXHIBIT re 180 Reply to Response to Motion,,, Exhibit B by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 06/07/2018)
2018-06-07
1
REDACTED VERSION of 191 Exhibit to a Document by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 06/07/2018)
2018-06-07
1
[SEALED] MOTION to Amend/Correct 1 Complaint,, - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit of Amy Dudash, # 2 Amended Complaint, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Dudash, Amy) (Entered: 06/07/2018)
2018-06-07
1
CERTIFICATE OF SERVICE of Motion to Amend by Baxalta GmbH, Baxalta Incorporated re 193 MOTION to Amend/Correct 1 Complaint,, (Dudash, Amy) (Entered: 06/07/2018)
2018-06-07
1
[SEALED] MEMORANDUM in Support re 193 MOTION to Amend/Correct 1 Complaint,, filed by Baxalta GmbH, Baxalta Incorporated.Answering Brief/Response due date per Local Rules is 6/21/2018. (Dudash, Amy) (Entered: 06/07/2018)
2018-06-07
1
NOTE: We have removed the deadline for a reply brief that was automatically generated by the system at ECF No. 190 . (nmg)
2018-06-07
1
No Actions
ORAL ORDER: On May 29, 2018, Patients for Access to Advanced Hemophilia Therapy (PAAHT) moved for leave to file an amicus brief in opposition to plaintiffs motion for a preliminary injunction. ECF No. 182 . Plaintiffs responded with their objections to the filing of the amicus brief. ECF No. 189 . Having considered plaintiffs objections, PAAHTs motion is GRANTED. Ordered by Judge Timothy B. Dyk on 6/7/2018. (nmg)
2018-06-07
1
No Actions
Remark
2018-06-07
1
No Actions
Oral Order
2018-06-07
1
No Actions
[SEALED] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Privilege Claim. (Attachments: # 1 Exhibit A)(Dudash, Amy) (Entered: 06/08/2018)
2018-06-08
1
CERTIFICATE OF SERVICE of Letter to The Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated re 196 Letter (Dudash, Amy) (Entered: 06/08/2018)
2018-06-08
1
[SEALED] Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding the Disputed Privilege Claim. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Balick, Steven) (Entered: 06/08/2018)
2018-06-08
1
NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 06/08/2018)
2018-06-08
1
Letter to The Honorable Judge Timothy B. Dyk from Karen E. Keller - re 187 Letter,,. (Keller, Karen) (Entered: 06/08/2018)
2018-06-08
1
[SEALED] Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding Claim Construction for Purposes of Baxalta's Motion for a Preliminary Injunction. (Balick, Steven) (Entered: 06/09/2018)
2018-06-09
1
Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Supplemental Claim Construction Brief for Purposes of Preliminary Injunction. (Attachments: # 1 Exhibit 1 to Supplemental Claim Construction Letter Brief, # 2 Exhibit 2 to Supplemental Claim Construction Letter Brief)(Dudash, Amy) (Entered: 06/09/2018)
2018-06-09
1
Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Supplemental Claim Construction Brief for Purposes of Preliminary Injunction. (Attachments: # 1 Exhibit 1 to Supplemental Claim Construction Letter Brief, # 2 Exhibit 2 to Supplemental Claim Construction Letter Brief)(Dudash, Amy) (Entered: 06/09/2018)
2018-06-09
2
Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Supplemental Claim Construction Brief for Purposes of Preliminary Injunction. (Attachments: # 1 Exhibit 1 to Supplemental Claim Construction Letter Brief, # 2 Exhibit 2 to Supplemental Claim Construction Letter Brief)(Dudash, Amy) (Entered: 06/09/2018)
2018-06-09
2
REDACTED VERSION of 201 Letter by Genentech, Inc.. (Mayo, Andrew) (Entered: 06/11/2018)
2018-06-11
1
REDACTED VERSION of 187 Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Redacted Exhibit A, # 2 Redacted Exhibit B, # 3 Redacted Exhibit C, # 4 Redacted Exhibit D, # 5 Redacted Exhibit E, # 6 Redacted Exhibit F, # 7 Redacted Exhibit G, # 8 Redacted Exhibit H, # 9 Redacted Exhibit I, # 10 Redacted Exhibit J, # 11 Redacted Exhibit K, # 12 Redacted Exhibit L, # 13 Redacted Exhibit M, # 14 Redacted Exhibit N, # 15 Redacted Exhibit O, # 16 Redacted Exhibit P, # 17 Redacted Exhibit Q, # 18 Redacted Exhibit R, # 19 Redacted Exhibit S, # 20 Redacted Exhibit T)(Dudash, Amy) (Entered: 06/12/2018)
2018-06-12
1
Minute Entry for proceedings held before Judge Timothy B. Dyk - Oral Argument held on 6/12/2018. Parties to provide additional supplemental briefing with respect to Exhibit JJ by close of business on 6/13/2018. (Court Reporter Susan Marie Migatz.)(fms)
2018-06-12
1
No Actions
[SEALED] Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding the Disputed Privilege Claim. (Balick, Steven) (Entered: 06/13/2018)
2018-06-13
1
[SEALED] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding the Disputed Privilege Claim. (Attachments: # 1 Exhibit A)(Dudash, Amy) (Entered: 06/13/2018)
2018-06-13
1
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Motion Hearing held on 6/13/2018 re 41 Motion for Preliminary Injunction. (Court Reporter Susan Marie Migatz.) (ceg)
2018-06-13
1
No Actions
REDACTED VERSION of 193 MOTION to Amend/Correct 1 Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit of Amy Dudash, # 2 Amended Complaint, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Dudash, Amy) (Entered: 06/14/2018)
2018-06-14
1
REDACTED VERSION of 195 MEMORANDUM in Support of Motion to Amend/Correct Complaint by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 06/14/2018)
2018-06-14
1
REDACTED VERSION of 196 Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Privilege Claim by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A)(Dudash, Amy) (Entered: 06/14/2018)
2018-06-14
1
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Motion Hearing held on 6/14/2018 re 41 Motion for Preliminary Injunction. (Court Reporter Susan Marie Migatz.) (ceg)
2018-06-14
1
No Actions
REDACTED VERSION of 198 Letter by Genentech, Inc.. (Attachments: # 1 Exhibit 1-2)(Mayo, Andrew) (Entered: 06/15/2018)
2018-06-15
1
REDACTED VERSION of 205 Letter by Genentech, Inc.. (Balick, Steven) (Entered: 06/19/2018)
2018-06-19
1
REDACTED VERSION of 206 Letter by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A - REDACTED)(Dudash, Amy) (Entered: 06/19/2018)
2018-06-19
1
ORAL ORDER: Oral argument regarding the motion for a preliminary injunction has been set in this matter for Monday, July 2, 2018, at 1:30 PM at the U.S. Court of Appeals for the Federal Circuit, Washington, DC. The parties shall file proposed findings of fact and conclusions of law concerning the preliminary injunction, not to exceed 25 double-spaced pages, by the close of business on July 9, 2018. The parties shall simultaneously file reply proposed findings of fact and conclusions of law, not to exceed 10 double-spaced pages, by the close of business on July 16, 2018. Ordered by Judge Timothy B. Dyk on 6/19/2018. (nmf)
2018-06-19
1
No Actions
Official Transcript of Motion to Dismiss held on 06-12-18 before Judge Timothy B. Dyk. Court Reporter/Transcriber Susan Migatz. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/11/2018. Redacted Transcript Deadline set for 7/23/2018. Release of Transcript Restriction set for 9/18/2018. (lad) (Entered: 06/20/2018)
2018-06-20
1
Official Transcript of Preliminary Injunction Hearing (Day 1) held on 06-13-18 before Judge Timothy B. Dyk. Court Reporter/Transcriber Susan Migatz. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/11/2018. Redacted Transcript Deadline set for 7/23/2018. Release of Transcript Restriction set for 9/18/2018. (lad) (Entered: 06/20/2018)
2018-06-20
1
Official Transcript of Preliminary Injunction Hearing (Day 2) held on 06-14-18 before Judge Timothy B. Dyk. Court Reporter/Transcriber Susan Migatz. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/11/2018. Redacted Transcript Deadline set for 7/23/2018. Release of Transcript Restriction set for 9/18/2018. (lad) (Entered: 06/20/2018)
2018-06-20
1
[SEALED] ANSWERING BRIEF in Opposition re 193 MOTION to Amend/Correct 1 Complaint,, filed by Genentech, Inc..Reply Brief due date per Local Rules is 6/28/2018. (Balick, Steven) (Entered: 06/21/2018)
2018-06-21
1
[SEALED] DECLARATION re 216 Answering Brief in Opposition (Declaration of Eric Alan Stone), by Genentech, Inc.. (Attachments: # 1 Exhibit A)(Balick, Steven) (Entered: 06/21/2018)
2018-06-21
1
AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. Amendment to 42 MEMORANDUM in Support, Exhibit A - Proposed Order. (Dudash, Amy) (Entered: 06/25/2018)
2018-06-25
1
STIPULATION Regarding Extension of Deadlines for Submission of Opening and Responsive Proposed Findings of Fact and Conclusions of Law with Respect to the Pending Motion for Preliminary Injunction, and Regarding Deadline for Submission of Responsive Markman Briefs, by Genentech, Inc.. (Balick, Steven) (Entered: 06/26/2018)
2018-06-26
1
Joint STIPULATION re Chugai Pharmaceutical Co. Ltd. by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Dudash, Amy) (Entered: 06/26/2018)
2018-06-26
1
AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. Amendment to 220 Stipulation - Corrected Exhibit B. (Dudash, Amy) (Entered: 06/27/2018)
2018-06-27
1
ORDER approving 219 STIPULATION Regarding Extension of Deadlines for Submission of Opening and Responsive Proposed Findings of Fact and Conclusions of Law with Respect to the Pending Motion for Preliminary Injunction, and Regarding Deadline for Submission of Responsive Markman Briefs. The deadlines by which plaintiffs and defendant Genentech, Inc. shall file proposed findings of fact and conclusions of law with respect to the pending motion for preliminary injunction, as originally established in the Court's June 19, 2018 oral order, are extended, with simultaneous opening papers not to exceed 25 double-spaced pages due by 6:00 p.m. EDT on July 11, 2018, and simultaneous responsive papers not to exceed 10 double-spaced pages due by 6:00 p.m. EDT on July 18, 2018. ORDER Re-setting Scheduling Order deadlines: ( Claim Construction Answering Briefs due by 7/16/2018.) Signed by Judge Timothy Belcher Dyk on 6/26/2018. (nmf) (Entered: 06/27/2018)
2018-06-27
1
REDACTED VERSION of 216 Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew) (Entered: 06/28/2018)
2018-06-28
1
REDACTED VERSION of 217 Declaration of Eric Alan Stone by Genentech, Inc.. (Mayo, Andrew) (Entered: 06/28/2018)
2018-06-28
1
[SEALED] REPLY to Response to Motion re 193 MOTION to Amend/Correct 1 Complaint,, filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 06/28/2018)
2018-06-28
1
CERTIFICATE OF SERVICE of Baxalta's Sealed Reply Brief in Support of Motion to Amend the Complaint by Baxalta GmbH, Baxalta Incorporated re 225 Reply to Response to Motion (Dudash, Amy) (Entered: 06/28/2018)
2018-06-28
1
Minute Entry for proceedings held before Judge Timothy B. Dyk Oral argument held on 7/2/2018. Pursuant to the parties stipulation, Chugai shall make available a witness or witnesses for a Rule 30(b)(6) deposition. If the deposition is taken outside the United States, it shall be taken in accordance with the appropriate foreign law. Within five days of completion of the deposition, Baxalta shall file a proposed order dismissing Chugai in accordance with the stipulation. As stated on the record, Baxaltas motion for leave to amend its complaint is GRANTED. (Court Reporter Kenneth Norris present.) (nmg)
2018-07-02
1
No Actions
REDACTED VERSION of 225 Reply to Response to Motion by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 07/05/2018)
2018-07-05
1
NOTICE of Withdrawal of Appearance of Jessica A. Stow as counsel for Plaintiffs by Baxalta GmbH, Baxalta Incorporated (Dudash, Amy) (Entered: 07/09/2018)
2018-07-09
1
Official Transcript of Oral Argument held on 7/2/2018 before Judge Timothy B. Dyk. Court Reporter/Transcriber Kenneth Norris,Telephone number 1-800-211-3376. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 7/31/2018. Redacted Transcript Deadline set for 8/10/2018. Release of Transcript Restriction set for 10/9/2018. (crb) (Entered: 07/10/2018)
2018-07-10
1
[SEALED] Proposed Findings of Fact by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 07/11/2018)
2018-07-11
1
CERTIFICATE OF SERVICE of Sealed Findings of Fact and Conclusions of Law by Baxalta GmbH, Baxalta Incorporated re 230 Proposed Findings of Fact (Dudash, Amy) (Entered: 07/11/2018)
2018-07-11
1
Proposed Findings of Fact by Genentech, Inc.. (Balick, Steven) (Entered: 07/11/2018)
2018-07-11
1
DECLARATION of David E. Cole in Support of Genentech's Responsive Claim Construction Brief Regarding Remaining Claim Terms, by Genentech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Balick, Steven) (Entered: 07/16/2018)
2018-07-16
1
CLAIM CONSTRUCTION ANSWERING BRIEF re 160 Claim Construction Opening Brief filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Affidavit of Amy Dudash, # 2 Exhibit 1)(Dudash, Amy) (Entered: 07/16/2018)
2018-07-16
1
[SEALED] CLAIM CONSTRUCTION ANSWERING BRIEF filed by Genentech, Inc.. (Balick, Steven) (Entered: 07/16/2018)
2018-07-16
1
Statement
2018-07-16
1
JOINDER by Chugai Pharmaceutical Co., Ltd., joining in 235 Claim Construction Answering Brief . (Keller, Karen) (Entered: 07/17/2018)
2018-07-17
1
NOTICE OF SERVICE of Genentech, Inc.'s Third Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Mayo, Andrew) (Entered: 07/17/2018)
2018-07-17
1
First AMENDED COMPLAINT for Patent Infringement and Declaratory Judgment of Patent Infringement against Chugai Pharmaceutical Co., Ltd., Genentech, Inc.- filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 07/18/2018)
2018-07-18
1
ANSWER to Amended Complaint, re: 239 Amended Complaint with Jury Demand, COUNTERCLAIM against Baxalta GmbH, Baxalta Incorporated by Genentech, Inc.(nmf) (Entered: 07/18/2018)
2018-07-18
1
REDACTED VERSION of 230 Proposed Findings of Fact by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 07/18/2018)
2018-07-18
1
[SEALED] STATEMENT re 232 Proposed Findings of Fact by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 07/18/2018)
2018-07-18
1
CERTIFICATE OF SERVICE of Baxalta's Sealed Response to Genentech's Findings of Fact and Conclusions of Law by Baxalta GmbH, Baxalta Incorporated re 242 Statement (Dudash, Amy) (Entered: 07/18/2018)
2018-07-18
1
STATEMENT [Defendant Genentech's Reply to Baxalta's Proposed Findings of Fact and Conclusions of Law (D.I. 230)] by Genentech, Inc.. (Mayo, Andrew) (Entered: 07/18/2018)
2018-07-18
1
[SEALED] Letter to The Honorable Timothy B. Dyk from Amy Dudash regarding Preliminary Injunction Exhibits. (Attachments: # 1 Exhibit A - Joint Exhibit List, # 2 Exhibit Vol. 1, # 3 Exhibit Vol. 2, # 4 Exhibit Vol. 3, # 5 Exhibit Vol. 4, # 6 Exhibit Vol. 5)(Dudash, Amy) (Entered: 07/18/2018)
2018-07-18
1
CERTIFICATE OF SERVICE of Letter to The Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated re 245 Letter, (Dudash, Amy) (Entered: 07/18/2018)
2018-07-18
1
CORRECTING ENTRY: The answer which was previously docketed as a statement has been deleted and re-docketed as an answer to the amended complaint with counterclaim and jury demand now that the amended complaint has been filed. (SEE D.I. 240 ) (nmf)
2018-07-18
1
No Actions
Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding Genentech's Response to Baxalta's Objections to Preliminary Injunction Exhibits - re 245 Letter,. (Attachments: # 1 Exhibit A-D)(Balick, Steven) (Entered: 07/23/2018)
2018-07-23
1
ORDER Setting Follow-up Teleconference: Plaintiffs' Counsel to initiate the call. A Telephone Conference is set for 10/9/2018 at 10:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR.Signed by Judge Mary Pat Thynge on 7/23/2018. (fms) (Entered: 07/23/2018)
2018-07-23
1
REDACTED VERSION of 235 Claim Construction Answering Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 07/23/2018)
2018-07-23
1
PROPOSED ORDER and Commission for Depositions to be Taken in Japan by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 07/23/2018)
2018-07-23
1
Letter to The Honorable Timothy B. Dyk from Amy Dudash regarding the Confidential Preliminary Injunction Hearing Exhibits. (Attachments: # 1 Exhibit B)(Dudash, Amy) (Entered: 07/23/2018)
2018-07-23
1
REDACTED VERSION of 245 Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A - Joint Exhibit List, # 2 Exhibit Vol. 1 REDACTED, # 3 Exhibit Vol. 2 REDACTED, # 4 Exhibit Vol. 3 REDACTED, # 5 Exhibit Vol. 4 REDACTED, # 6 Exhibit Vol. 5 REDACTED)(Dudash, Amy) (Entered: 07/25/2018)
2018-07-25
1
REDACTED VERSION of 242 Statement [Response to Genentech's Post-Hearing Proposed Findings of Fact and Conclusions of Law] by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 07/25/2018)
2018-07-25
1
NOTICE requesting Clerk to remove James V. Razick as co-counsel.. (Balick, Steven) (Entered: 07/27/2018)
2018-07-27
1
ORDER re 251 Letter to The Honorable Timothy B. Dyk from Amy Dudash regarding the Confidential Preliminary Injunction Hearing Exhibits. (SEE ORDER FOR FURTHER DETAILS). Signed by Judge Timothy Belcher Dyk on 7/26/2018. (crb) (Entered: 07/30/2018)
2018-07-30
1
ORDER and Commission for Depositions to be Taken in Japan. Signed by Judge Timothy Belcher Dyk on 7/25/2018. (crb) (Entered: 07/30/2018)
2018-07-30
1
Amended PROPOSED ORDER and Commission for Depositions to be Taken in Japan by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 08/01/2018)
2018-08-01
1
[SEALED] Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding Response to the Court's July 30, 2018 Order - re 255 Order. (Balick, Steven) (Entered: 08/01/2018)
2018-08-01
1
[SEALED] DECLARATION re 258 Letter (Declaration of Gina Chapman in Support of Genentech's Request to Maintain Confidentiality of Certain Materials Containing Competitively Sensitive Information) by Genentech, Inc.. (Attachments: # 1 Exhibit A-B)(Balick, Steven) (Entered: 08/01/2018)
2018-08-01
1
Corrected ORDER and Commission for Depositions to be Taken in Japan. Signed by Judge Timothy Belcher Dyk on 8/3/2018. (nmg) (Entered: 08/06/2018)
2018-08-03
1
ANSWER to 240 Answer to Amended Complaint, Counterclaim [Plaintiffs' Answer to the Counterclaims of Defendant Genentech, Inc.] by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 08/06/2018)
2018-08-06
1
OPINION & ORDER denying 41 MOTION for Preliminary Injunction Signed by Judge Timothy Belcher Dyk on 8/7/2018. (nmf)
2018-08-07
1
NOTICE of Withdrawal of Appearance of Colm F. Connolly by Baxalta GmbH, Baxalta Incorporated (Barillare, Jody) (Entered: 08/07/2018)
2018-08-07
1
REDACTED VERSION of 258 Letter by Genentech, Inc.. (Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
REDACTED VERSION of 259 Declaration, (Declaration of Gina Chapman) by Genentech, Inc.. (Attachments: # 1 Exhibit A-B)(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Friedrich Scheiflinger filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Randolf Kerschbaumer filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Thomas Larmondra filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Noah Brown filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Michael Moye filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Gabi Gerstenbauer filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE to Take Deposition of Michael Dockal filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
NOTICE OF SERVICE of (1) Defendant Genentech's Notice of Deposition of Baxalta Pursuant to Fed. R. Civ. P. 30(b)(6); (2) Genentech's Responses and Objections to Baxalta's 30(b)(6) Notice; and (3) Genentech, Inc.'s Fourth Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Balick, Steven) (Entered: 08/08/2018)
2018-08-08
1
MOTION for Pro Hac Vice Appearance of Attorney Josephine Young, Naz Wehrli, Marissa C.M. Doran, and Alexander F. Atkins - filed by Genentech, Inc.. (Balick, Steven) (Entered: 08/09/2018)
2018-08-09
1
ORDER, The documents listed in Exhibit A to the parties' joint letter, ECF No. 254-1, are ADMITTED and are part of the preliminary injunction record. The parties' objections to inclusion of these documents are OVERRULED. Signed by Judge Timothy Belcher Dyk on 8/10/2018. (crb) (Entered: 08/10/2018)
2018-08-10
1
[SEALED] Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding Genentech's Request for an Order Compelling Baxalta to Respond to Discovery. (Attachments: # 1 Exhibit 1-10)(Balick, Steven) (Entered: 08/15/2018)
2018-08-15
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech's Third Requests for Production of Documents and Things re 238 Notice of Service filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 08/17/2018)
2018-08-17
1
ORDER granting 274 MOTION for Pro Hac Vice Appearance of Attorney Josephine Young, Naz Wehrli, Marissa C.M. Doran, and Alexander F. Atkins. Signed by Judge Timothy Belcher Dyk on 8/17/2018. (crb) (Entered: 08/20/2018)
2018-08-20
1
NOTICE OF SERVICE of Genentech, Inc.'s Second Set of Interrogatories (Nos. 12-24) and Genentech, Inc.'s Second Set of Requests for Admission to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Mayo, Andrew) (Entered: 08/21/2018)
2018-08-21
1
Pro Hac Vice Attorney Naz Wehrli for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-08-21
1
No Actions
Pro Hac Vice Attorney Alexander F. Atkins for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-08-21
1
No Actions
Pro Hac Vice Attorney Marissa C.M. Doran for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-08-21
1
No Actions
Pro Hac Vice Attorney Josephine Young for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
2018-08-21
1
No Actions
[SEALED] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Opposition to Genentech's Request for an Order Compelling Baxalta to Respond to Discovery - re 276 Letter. (Attachments: # 1 Exhibit A)(Dudash, Amy) (Entered: 08/22/2018)
2018-08-22
1
NOTICE OF SERVICE of Notice of Deposition of Qasim Rizvi and Notice of Deposition of Cristin Hubbard filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 08/23/2018)
2018-08-23
1
NOTICE OF SERVICE of Genentech, Inc.'s Fifth Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc.(Mayo, Andrew) Modified on 9/7/2018 (nmf). (Main Document 282 replaced on 9/7/2018) (nmf, ). (Entered: 08/23/2018)
2018-08-23
1
REDACTED VERSION of 276 Letter by Genentech, Inc.. (Attachments: # 1 Exhibit 1-10)(Mayo, Andrew) (Entered: 08/23/2018)
2018-08-23
1
NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 108-117) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 08/24/2018)
2018-08-24
1
NOTICE OF SERVICE of Defendant Genentech, Inc.'s First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 08/27/2018)
2018-08-27
1
REDACTED VERSION of 280 Letter by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A)(Dudash, Amy) (Entered: 08/29/2018)
2018-08-29
1
ORAL ORDER: The parties should be prepared to argue the discovery dispute raised in parties letters dated August 15, 2018, ECF No. 276, and August 22, 2018, ECF No. 280, at the Markman hearing scheduled for Thursday, September 13, 2018, at 10:00AM in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. Ordered by Judge Timothy B. Dyk on 8/19/18. (crb)
2018-08-29
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories (Nos. 21-27) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/05/2018)
2018-09-05
1
NOTICE OF SERVICE of Plaintiffs' Notices of Deposition Directed to Nancy Valente, Kate Skrable, Glenn Pierce, Bea Lavery, Gina Chapman, and Gallia Levy filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/05/2018)
2018-09-05
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech's Fourth Set of Requests for Production of Documents and Things (No. 108) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/07/2018)
2018-09-07
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Deposition (Topics 1-45) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/07/2018)
2018-09-07
1
CORRECTING ENTRY: Per request of counsel, the pdf of D.I. 282 has been replaced and the docket text corrected to reflect that this is the "Fifth" Set of Requests for the Production of Documents. (nmf)
2018-09-07
1
No Actions
ORAL ORDER: The Markman Hearing set for September 13, 2018, is rescheduled for September 21, 2018, at 11:00AM in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. Ordered by Judge Timothy B. Dyk on 9/12/18. (nmg)
2018-09-12
1
No Actions
PROPOSED ORDER Dismissing Defendant Chugai Pharmaceutical Co., Ltd. [Stipulated] by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 09/13/2018)
2018-09-13
1
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Status Conference held on 9/18/2018. (ceg)
2018-09-18
1
No Actions
Amended PROPOSED ORDER Dismissing Defendant Chugai Pharmaceutical Co., Ltd. and Stipulation by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 09/19/2018)
2018-09-19
1
SO ORDERED, 292 First Amended Stipulation and Order Dismissing Defendant Chugai Pharmaceutical Co., Ltd. Signed by Judge Timothy Belcher Dyk on 9/19/2018. (ceg) (Entered: 09/19/2018)
2018-09-19
1
ORAL ORDER: The Markman hearing scheduled for 9/21/2018 is cancelled and will be rescheduled for a later date. Ordered by Judge Timothy Belcher Dyk on 9/19/2018. (ceg)
2018-09-19
1
No Actions
Official Transcript of the Status Teleconference held on 9/18/2018 before Judge Timothy B. Dyk. Court Reporter Carol Connolly. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/11/2018. Redacted Transcript Deadline set for 10/22/2018. Release of Transcript Restriction set for 12/19/2018. (nmg) (Entered: 09/20/2018)
2018-09-20
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech, Inc.'s Second Set of Requests for Admission (Nos. 9-23) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/20/2018)
2018-09-20
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech, Inc.'s Second Set of Interrogatories (Nos. 12-24) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/21/2018)
2018-09-21
1
NOTICE OF SERVICE of Genentech's Objections and Responses to Baxalta's Second Set of Requests for Production filed by Genentech, Inc..(Mayo, Andrew) (Entered: 09/24/2018)
2018-09-24
1
NOTICE to Take Deposition of Gabi Gerstenbauer on September 28, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 09/24/2018)
2018-09-24
1
NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH Responses and Objections to Genetech, Inc.'s Fifth Set of Requests for the Production of Documents and Things filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/24/2018)
2018-09-24
1
ORAL ORDER: The Markman hearing previously scheduled for September 21, 2018, is now rescheduled for October 16, 2018, at 10:00 a.m. in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. Ordered by Judge Timothy B. Dyk on 9/25/18. (ceg)
2018-09-25
1
No Actions
NOTICE to Take Deposition of Michael Moye on October 3, 2018 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 09/26/2018)
2018-09-26
1
NOTICE to Take Deposition of Cristin Hubbard on October 2, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 09/26/2018)
2018-09-26
1
NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Genentech, Inc.'s Second Set of Interrogatories filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 10/01/2018)
2018-10-01
1
NOTICE OF SERVICE of Genentech, Inc.'s Supplemental Objections and Responses to Baxalta's Interrogatory No. 13 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 10/01/2018)
2018-10-01
1
Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding the Parties' Proposed Amendments to the Case Schedule (D.I. 174). (Balick, Steven) (Entered: 10/04/2018)
2018-10-04
1
STIPULATION Regarding the Parties' Proposed Amendments to the Case Schedule (D.I. 174), by Genentech, Inc.. (Balick, Steven) (Entered: 10/04/2018)
2018-10-04
1
NOTICE OF SERVICE of Genentech, Inc.'s Objections and Responses to Baxalta's Second Set of Interrogatories (Nos. 21-27) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 10/08/2018)
2018-10-08
1
MOTION for Issuance of Letters Rogatory Requiring the Testimony of Named Inventor Dr. Randolf Kerschbaumer (Unopposed) - filed by Genentech, Inc.. (Attachments: # 1 Exhibit 1 & 2)(Mayo, Andrew) (Entered: 10/12/2018)
2018-10-12
1
Letter to The Honorable Timothy B. Dyk from Andrew C. Mayo regarding request that the Court: 1) deem Baxalta to have admitted certain Requests for Admission; and 2) compel Baxalta to respond to certain Interrogatories and Document Requests. (Attachments: # 1 Exhibit 1-12)(Mayo, Andrew) (Entered: 10/12/2018)
2018-10-12
1
NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Genentech, Inc.'s Interrogatory No. 11 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 10/15/2018)
2018-10-15
1
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Markman Hearing held on 10/16/2018. As stated on the record, Genentech's motion to compel discovery of Baxalta's 2015 collaboration agreement with Novimmune S.A. to research and develop bispecific antibodies for the treatment of hemophilia A using Novimmune's bispecific-antibody technology, and Baxalta's 2017 license agreement with Novimmune to develop and commercialize those bispecific antibodies is GRANTED, but is DENIED without prejudice as to experimental data and the royalty rates and compensation paid to Novimmune. (Court Reporter: Ronda Thomas of Epiq Court Reporting). (ceg)
2018-10-16
1
No Actions
[SEALED] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Response to Genentech's letter Motion to Compel - re 308 Letter,. (Attachments: # 1 Exhibit A [SEALED], # 2 Exhibit B [SEALED], # 3 Exhibit C [SEALED], # 4 Exhibit D [SEALED])(Dudash, Amy) (Entered: 10/19/2018)
2018-10-19
1
EXHIBIT re 310 Letter, [Exhibits E-H] by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit Exhibit F, # 2 Exhibit Exhibit G, # 3 Exhibit H)(Dudash, Amy) (Entered: 10/19/2018)
2018-10-19
1
Letter to Honorable Judge Timothy B. Dyk from Amy M. Dudash regarding regarding Case Schedule. (Dudash, Amy) (Entered: 10/23/2018)
2018-10-23
1
PROPOSED ORDER to Amend the Schedule [STIPULATED] by Baxalta Incorporated. (Dudash, Amy) (Entered: 10/23/2018)
2018-10-23
1
PROPOSED ORDER (Stipulated Protective Order), by Genentech, Inc.. (Balick, Steven) (Entered: 10/23/2018)
2018-10-23
1
ORAL ORDER: The parties are directed to attempt to resolve the discovery disputes reflected in their letters dated October 12, 2018 (ECF No. 308 ), and October 19, 2018 (ECF No. 310 ). The parties are to present any unresolved disputes at a telephonic status conference on November 2, 2018 at 11:00 a.m. Ordered by Judge Timothy B. Dyk on 10/24/2018. (*a status conference is set for 11/2/2018 at 11:00 a.m.) (ceg)
2018-10-24
1
No Actions
REDACTED VERSION of 310 Letter, Response to Genentech's Letter Motion to Compel by Baxalta GmbH. (Attachments: # 1 Exhibit A-D [REDACTED])(Dudash, Amy) (Entered: 10/26/2018)
2018-10-26
1
ORDER Approving D.I. 314 Stipulated Protective Order filed by Genentech, Inc. Signed by Judge Timothy Belcher Dyk on 10/26/2018. (nmg) (Entered: 10/29/2018)
2018-10-29
1
ORDER Setting Mediation Conferences: A Mediation Conference is set for 4/10/2019 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/30/18. (cak) (Entered: 10/30/2018)
2018-10-30
1
NOTICE OF SERVICE of Genentech, Inc.'s Supplemental Objections and Responses to Baxalta's First Set of Interrogatories (Nos. 120) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 10/30/2018)
2018-10-30
1
NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Genentech, Inc.'s Interrogatory Nos. 4 and 7 and Plaintiffs' Supplemental Responses and Objections to Genentech's Interrogatory Nos. 15, 16, and 21-23 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/01/2018)
2018-11-01
1
Official Transcript of Markman Hearing held on 10/16/2018 before Judge Timothy Dyk. Court Reporter/Transcriber Ronda J. Thomas,Telephone number 312-386-2000. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 11/23/2018. Redacted Transcript Deadline set for 12/3/2018. Release of Transcript Restriction set for 1/31/2019. (crb) (Entered: 11/02/2018)
2018-11-02
1
ORAL ORDER: The telephonic status conference scheduled for November 2, 2018 at 11AM is canceled. Ordered by Judge Timothy B. Dyk on 11/2/2018. (crb)
2018-11-02
1
No Actions
NOTICE to Take Deposition of Gallia Levy on November 13, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/05/2018)
2018-11-05
1
NOTICE to Take Deposition of Gina Chapman on November 15, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/05/2018)
2018-11-05
1
NOTICE to Take Deposition of Kate Skrable on November 16, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/05/2018)
2018-11-05
1
NOTICE to Take Deposition of Qasim Rizvi on December 4, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/05/2018)
2018-11-05
1
ORDER Amending Schedule: Fact Discovery completed by 12/14/2018. Opening Expert Reports due by 1/18/2019. Rebuttal Expert Reports due by 2/15/2019. Reply Expert Reports due by 3/8/2019. Expert Discovery due by 4/19/2019. Motions for Summary Judgment due by 5/3/2019. Responses to Motions for Summary Judgment due by 5/17/2019. Reply to Motions for Summary Judgment due by 5/24/2019. Signed by Judge Timothy Belcher Dyk on 11/7/2018. (nmg) (Entered: 11/07/2018)
2018-11-07
1
NOTICE OF SERVICE of Letter Rogatory to Compel the Testimony of Dr. Randolf Kerschbaumer, filed by Genentech, Inc..(Balick, Steven) (Entered: 11/08/2018)
2018-11-08
1
NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Genetech, Inc.'s Second Set of Requests for Admission (Nos. 10-13) filed by Baxalta Incorporated.(Dudash, Amy) (Entered: 11/27/2018)
2018-11-27
1
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Response and Objections to Genentech, Inc.'s interrogatory No. 4 filed by Baxalta Incorporated.(Dudash, Amy) (Entered: 11/27/2018)
2018-11-27
1
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses and Objections to Genentech, Inc.'s Interrogatory No. 11 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/30/2018)
2018-11-30
1
OPINION AND ORDER. Signed by Judge Timothy Belcher Dyk on 12/3/2018. (nmg)
2018-12-03
1
STIPULATION Seeking to Amend Case Schedule, by Genentech, Inc.. (Balick, Steven) (Entered: 12/12/2018)
2018-12-12
1
STIPULATION Seeking to Amend Case Schedule, by Genentech, Inc.. (Balick, Steven) (Entered: 12/14/2018)
2018-12-14
1
Stipulation and Order to Amend the Schedule: ( Fact Discovery completed by 2/8/2019, Opening Expert Reports due by 3/15/2019, Rebuttal Expert Reports due by 4/12/2019, Expert Discovery due by 6/14/2019.) (See Order for Additional Deadlines). Signed by Judge Timothy Belcher Dyk on 12/17/2018. (nmg) (Entered: 12/17/2018)
2018-12-17
1
STIPULATION AND FINAL JUDGMENT, by Genentech, Inc.. (Balick, Steven) (Entered: 01/25/2019)
2019-01-25
1
STIPULATION AND FINAL JUDGMENT by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/31/2019)
2019-01-31
1
Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Takeda Pharmaceutical Company Limited for Baxalta GmbH, Baxalta Incorporated filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/31/2019)
2019-01-31
1
FINAL JUDGMENT is entered in favor of Genentech, Inc. and against Baxalta Incorporated on all claims asserted in the operative complaint. Genetech's counterclaims for declaratory judgment of non-infringement and a declaratory judgment of invalidity are dismissed without prejudice (*see Order for further details) (*CASE CLOSED). Signed by Judge Timothy Belcher Dyk on 1/31/2019. (ceg) (Entered: 02/01/2019)
2019-02-01
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,033,590. (Attachments: # 1 Approved Final Judgment)(ceg) (Entered: 02/01/2019)
2019-02-01
1
NOTICE OF APPEAL to the Federal Circuit of 330 Memorandum and Order, 337 Judgment, . Appeal filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 02/08/2019)
2019-02-08
1
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 339 Notice of Appeal (Federal Circuit). (ddp)
2019-02-08
1
No Actions
APPEAL - Credit Card Payment of $505.00 received re 339 Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. ( Filing fee $505, receipt number 0311-2565602.) (Dudash, Amy)
2019-02-08
1
No Actions
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 339 Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Case Number 19-1527. Entry of Appearance due 02/26/2019. Certificate of Interest is due on 02/26/2019. Docketing Statement due 02/26/2019. Appellants' brief is due 04/15/2019. (bkb) (Entered: 02/12/2019)
2019-02-12
1
ORAL ORDER re 317 Order Setting Mediation Conferences: The mediation scheduled for 4/10/19 and the mediation submission due date of 3/25/19 are cancelled. Ordered by Judge Mary Pat Thynge on 2/13/19. (cak) (Entered: 02/13/2019)
2019-02-13
1
TRANSCRIPT REQUEST by Baxalta GmbH, Baxalta Incorporated for proceedings held on June 12, 2018, June 13, 2018, June 14, 2018, September 18, 2018, and October 16, 2018 before Judge Timothy Belcher Dyk, (Dudash, Amy) (Entered: 02/20/2019)
2019-02-20
1
MOTION (Genentech's Unopposed Motion to Perpetuate the Testimony of Austrian Citizen and Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # 1 Text of Proposed Order)(Balick, Steven) (Entered: 09/03/2019)
2019-09-03
1
[SEALED] MEMORANDUM in Support re 343 MOTION (Genentech's Unopposed Motion to Perpetuate the Testimony of Austrian Citizen and Named Inventor Dr. Randolf Josef Kerschbaumer) filed by Genentech, Inc..Answering Brief/Response due date per Local Rules is 9/17/2019. (Attachments: # 1 Exhibit A-C)(Balick, Steven) (Entered: 09/03/2019)
2019-09-03
1
REDACTED VERSION of 344 MEMORANDUM in Support, by Genentech, Inc.. (Attachments: # 1 Exhibit A-C)(Balick, Steven) (Entered: 09/03/2019)
2019-09-03
1
ORDER granting 343 MOTION (Genentech's Unopposed Motion to Perpetuate the Testimony of Austrian Citizen and Named Inventor Dr. Randolf Josef Kerschbaumer). Signed by Judge Timothy Belcher Dyk on 9/10/2019. (lam) (Entered: 09/10/2019)
2019-09-10
1
MOTION (Genentech's Unopposed Motion for Issuance of a Letter Request to the Austrian District Court for Permission to Use a Stenographer During the Austrian Hearing to Take the Testimony of Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Balick, Steven) (Entered: 11/04/2019)
2019-11-04
1
ORDER granting 347 MOTION (Genentech's Unopposed Motion for Issuance of a Letter Request to the Austrian District Court for Permission to Use a Stenographer During the Austrian Hearing to Take the Testimony of Named Inventor Dr. Randolf Josef Kerschbaumer). The requested letter in revised form is available for pickup. Signed by Judge Timothy Belcher Dyk on 11/6/19. (lam) (Entered: 11/06/2019)
2019-11-06
1
ORDER The court has received an untranslated copy of the transcript from the deposition of Dr. Randolf Josef Kerschbaumer. The parties should advise as to how they would like to proceed. Signed by Judge Timothy Belcher Dyk on 2/11/2020. (lam)
2020-02-11
1
No Actions
Order
2020-02-11
1
No Actions
Order
2020-02-20
1
No Actions
ORDER Per the request of both parties, the court has transmitted the untranslated copy of the transcript from the deposition of Dr. Randolf Josef Kerschbaumer to counsel for Genentech. Signed by Judge Timothy Belcher Dyk on 2/20/2020. (lam)
2020-02-20
1
No Actions
NOTICE of Withdrawal of Appearance of Jesse T. Dyer as counsel for Plaintiffs by Baxalta GmbH, Baxalta Incorporated (Dudash, Amy) (Entered: 05/26/2020)
2020-05-26
1
MANDATE of USCA as to 339 Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Decision: Vacated and Remanded. (Attachments: # 1 Opinion, # 2 Judgment)(kmd) (Entered: 10/05/2020)
2020-10-05
1
NOTICE of of Withdrawal of Certain Pro Hac Vice Counsel by Baxalta GmbH, Baxalta Incorporated (Dudash, Amy) (Entered: 10/05/2020)
2020-10-05
1
ORAL ORDER: On August 27, 2020, the U.S. Court of Appeals for the Federal Circuit issued its decision vacating this court's judgment of noninfringement and remanding the case to this court. Baxalta Inc. v. Genentech, Inc., 972 F.3d 1341, 1349 (Fed. Cir. 2020). The Federal Circuit's mandate issued on October 5, 2020. ECF No. 350. Given the Federal Circuit's decision, a telephonic status conference is scheduled for October 14, 2020, at 2:00 PM. The parties should be prepared to discuss a new scheduling order and related matters. Counsel for plaintiffs shall initiate the call to chambers once all participants are on the line. Counsel shall also arrange for a court reporter. Ordered by Judge Timothy Belcher Dyk on 10/8/2020. (kmd) Modified on 10/8/2020 (kmd). (Entered: 10/08/2020)
2020-10-08
1
Order Setting Teleconference AND Oral Order
2020-10-08
1
No Actions
Joint Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Scheduling for Case Going Forward - re 352 Oral Order,,,, Order Setting Teleconference,,,. (Dudash, Amy) (Entered: 10/13/2020)
2020-10-13
1
ORAL ORDER: As discussed during today's telephonic status conference, the parties shall file an updated proposed scheduling order on or before October 21, 2020. Ordered by Judge Timothy B. Dyk on October 14, 2020. (cna, ) (Entered: 10/14/2020)
2020-10-14
1
Oral Order
2020-10-14
1
No Actions
Joint PROPOSED ORDER Joint Proposed Scheduling Order re 354 Oral Order by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 10/21/2020)
2020-10-21
1
SCHEDULING ORDER. Signed by Judge Timothy Belcher Dyk on 10/23/2020. (amf) (Entered: 10/23/2020)
2020-10-23
1
NOTICE OF SERVICE of Genentech, Inc.'s Third Set of Requests for Admission (Nos. 24-42) and Genentech, Inc.'s Third Set of Interrogatories (Nos. 25-27) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 11/11/2020)
2020-11-11
1
NOTICE OF SERVICE of Genentech, Inc.'s Second Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 11/13/2020)
2020-11-13
1
SUBPOENA filed by Baxalta GmbH, Baxalta Incorporated directed to Qasim Rizvi for December 16, 2020 at 9:00 AM Central (Dudash, Amy) (Entered: 11/20/2020)
2020-11-20
1
SUBPOENA Returned Executed as to Qasim Rizvi on 11/21/2020 (Dudash, Amy) (Entered: 11/24/2020)
2020-11-24
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Third Set of Requests for Admission (Nos. 24-42) and Responses and Objections to Third Set of Interrogatories (Nos. 25-27) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/25/2020)
2020-11-25
1
NOTICE OF SERVICE of Genentech, Inc.'s Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Genentech, Inc.'s Third Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Balick, Steven) (Entered: 11/25/2020)
2020-11-25
1
NOTICE OF SERVICE of Plaintiffs' First Amended Rule 26(a)(1) Initial Disclosures filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 11/30/2020)
2020-11-30
1
Status Conference
2020-12-04
1
No Actions
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - a Telephonic Status Conference held on 10/14/2020, at 2:00 PM (Call lasted for 12 minutes). (Court Reporter was present) (myr)
2020-12-04
1
No Actions
NOTICE OF SERVICE of Plaintiffs' (i) Supplemental Responses and Objections to Genentech Inc.'s Interrogatory Nos. 3, 7, 10 and 11 of Genentech's First Set of Interrogatories, (ii) Supplemental Responses and Objections to Genentech Inc.'s Interrogatory Nos. 15, 16, 19 and 21-24 of Genentech Inc.'s Second Set of Interrogatories, and (iii) First Supplemental Responses and Objections to Genentech Inc.'s Second Set of Requests for Admission (Nos. 14-23) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 12/07/2020)
2020-12-07
1
NOTICE OF SERVICE of Genentech, Inc.'s Sixth Set of Requests for the Production of Documents and Things (Request Nos. 113-117) filed by Genentech, Inc..(Balick, Steven) (Entered: 12/08/2020)
2020-12-08
1
Joint STIPULATION and Proposed Order Concerning the Protocol for Conducting Remote Depositions by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 12/18/2020)
2020-12-18
1
STIPULATION AND ORDER Concerning the Protocol for Conducting Remote Depositions. Signed by Judge Timothy Belcher Dyk on 12/22/2020. (amf) (Entered: 12/22/2020)
2020-12-22
1
NOTICE to Take Deposition of David Chaudry on January 27, 2021 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/06/2021)
2021-01-06
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech's Sixth Set of Requests for the Production of Documents and Things (Nos. 113-117) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/07/2021)
2021-01-07
1
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/13/2021)
2021-01-13
1
NOTICE to Take Deposition of Friedrich Dorner on January 28, 2021 filed by Genentech, Inc..(Balick, Steven) (Entered: 01/14/2021)
2021-01-14
1
NOTICE to Take Deposition of Rebecca Carty on February 10, 2021 filed by Genentech, Inc..(Balick, Steven) (Entered: 01/14/2021)
2021-01-14
1
NOTICE to Take Deposition of Friedrich Scheiflinger on February 17, 2021 filed by Genentech, Inc..(Balick, Steven) (Entered: 01/14/2021)
2021-01-14
1
NOTICE OF SERVICE of Genentech, Inc.'s Amended Notice of Rule 30(b)(6) Deposition to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Balick, Steven) (Entered: 01/14/2021)
2021-01-14
1
MOTION for Pro Hac Vice Appearance of Attorney Olga Berson, Ph.D. - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certification of Olga Berson, Ph.D.)(Dudash, Amy) (Entered: 01/18/2021)
2021-01-18
1
NOTICE to Take Deposition of Suha Patel on February 12, 2021 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/19/2021)
2021-01-19
1
NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 117-138), Third Set of Interrogatories (No. 28), and Second Set of Requests for Admission Nos. 4-39) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/20/2021)
2021-01-20
1
NOTICE OF SERVICE of Genentech, Inc.'s Seventh Set of Requests for the Production of Documents and Things (Request No. 118) filed by Genentech, Inc..(Balick, Steven) (Entered: 01/21/2021)
2021-01-21
1
NOTICE OF SERVICE of Plaintiffs' Fourth Set of Interrogatories (Nos. 29-30) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/21/2021)
2021-01-21
1
SO ORDERED, re D.I. 375 MOTION for Pro Hac Vice Appearance of Attorney Olga Berson, Ph.D. filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 1/22/2021. (myr) (Entered: 01/22/2021)
2021-01-22
1
Pro Hac Vice Attorney Olga Berson for Baxalta GmbH and Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
2021-01-25
1
No Actions
Add Attorneys - PHV only
2021-01-25
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Response to Second Set of Interrogatories (No. 24), Supplemental Response to First Set of Interrogatories (No. 10-11) and Response to Third Set of Interrogatories (No. 26) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 01/28/2021)
2021-01-28
1
NOTICE OF SERVICE of Genentech Inc.'s Supplemental Objections and Responses to Baxalta Incorporated's and Baxalta GmbH's Interrogatory Nos. 10, 23, and 24 filed by Genentech, Inc..(Mayo, Andrew) (Entered: 01/29/2021)
2021-01-29
1
NOTICE OF SERVICE of Defendant Genentech, Inc.'s Initial Non-Infringement Contentions and Defendant Genentech, Inc.'s First Supplemental Invalidity Contentions filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/03/2021)
2021-02-03
1
ORAL ORDER, On February 2, 2021, the parties notified the court that they are at an impasse regarding various discovery disputes. It is hereby ORDERED that (1) defendants shall file an opening letter brief on or before Friday, February 5, 2021, addressing the disputes; and (2) plaintiffs shall file a responsive letter brief on or before Friday, February 12, 2021, addressing the disputes. The parties' letter briefs shall be no longer than seven pages, double spaced. It is further ORDERED that a telephonic hearing on the discovery disputes is scheduled for Wednesday, February 17, 2021, at 2:00 PM. Counsel for defendants shall initiate the call to chambers once all participants are on the line. Counsel for defendants shall also arrange for a court reporter. Entered by Judge Timothy Belcher Dyk on 2/3/2021. (nmg)
2021-02-03
1
No Actions
~Util - Set Hearings AND Oral Order AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2021-02-03
1
No Actions
~Util - Set Hearings AND ~Util - Set Briefing Schedule - open,ans,reply,surreply AND Oral Order
2021-02-03
1
No Actions
~Util - Set Briefing Schedule - open,ans,reply,surreply AND ~Util - Set Hearings AND Oral Order
2021-02-03
1
No Actions
NOTICE OF SERVICE of Notice of Subpoenas filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/05/2021)
2021-02-05
1
[SEALED] Letter to The Honorable Timothy B. Dyk from Andrew C. Mayo regarding request that the Court compel Baxalta to supplement certain Interrogatories Responses and Renewed Request for Production of collaboration agreement with Novimmune S.A.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J)(Mayo, Andrew) (Entered: 02/05/2021)
2021-02-05
1
[SEALED] Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding pursuant to Court's February 3, 2021 Oral Order. (Attachments: # 1 Exhibit 1 SEALED, # 2 Exhibit 2 SEALED, # 3 Exhibit 3 SEALED, # 4 Exhibit 4 SEALED, # 5 Exhibit 5 SEALED, # 6 Exhibit 6 SEALED)(Dudash, Amy) (Entered: 02/12/2021)
2021-02-12
1
CERTIFICATE OF SERVICE of Plaintiffs' Letter and Exhibits 1-6 filed under seal [D.I. 386] by Baxalta GmbH, Baxalta Incorporated re 386 Letter, (Dudash, Amy) (Entered: 02/12/2021)
2021-02-12
1
REDACTED VERSION of 385 Letter, by Genentech, Inc.. (Attachments: # 1 Exhibit A-J)(Mayo, Andrew) (Entered: 02/12/2021)
2021-02-12
1
NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's Amended Notice of 30(b)(6) Deposition (Topics 1-28) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 02/17/2021)
2021-02-17
1
Minute Entry for proceedings held before Judge Timothy Belcher Dyk - A Telephonic Hearing on the parties' discovery dispute held on February 17, 2021, at 2:00 PM. Baxalta Inc. ordered to supplement its response to Genentech, Inc.'s Interrogatory 9. Remaining relief requested denied without prejudice to the filing of a renewed motion at a later date. (Call lasted for 25 minutes) (Court Report was present) (myr)
2021-02-17
1
No Actions
REDACTED VERSION of 386 Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 02/19/2021)
2021-02-19
1
Telephone Conference
2021-02-19
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Validity Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 02/22/2021)
2021-02-22
1
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Interrogatory No. 1, Fourth Supplemental Objections and Responses to Second Set of Interrogatories (Nos. 7, 9), Fourth Supplemental Objections and Responses to Third Set of Interrogatories (Nos. 21, 22, 23) and Objections and Response to Seventh Set of Requests for Production (No. 118) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 02/22/2021)
2021-02-22
1
NOTICE OF SERVICE of (1) Genentech's Objections and Responses to Baxalta's Second Set of Requests for Admission (Nos. 4-39); (2) Genentech, Inc.'s Objections and Responses to Baxalta's Fourth Set of Interrogatories (No. 29-30); (3) Genentech, Inc.'s Objections and Responses to Baxalta's Third Set of Interrogatories (No. 28); and (4) Genentech's Objections and Responses to Baxalta's Third Set of Requests for Production (Nos. 117-138) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/23/2021)
2021-02-23
1
NOTICE OF SERVICE of Plaintiffs' Third Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 02/23/2021)
2021-02-23
1
NOTICE OF SERVICE of Genentech's Amended and Supplemental Responses and Objections to Baxalta's Rule 30(b)(6) Notice filed by Genentech, Inc..(Mayo, Andrew) (Entered: 02/26/2021)
2021-02-26
1
NOTICE OF SERVICE of (1) Defendant Genentech, Inc.'s Second Supplemental Invalidity Contentions; (2) Defendant Genentech, Inc.'s Supplemental Non-Infringement Contentions; and (3) Genentech Inc.'s Supplemental Objections and Responses to Baxalta Incorporated's and Baxalta GmbH's Second Set of Interrogatories (Nos. 21-23, 25 & 27) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 03/11/2021)
2021-03-11
1
NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to First Set of Interrogatories (Nos. 3, 5, 7, 9-11); Supplemental Responses and Objections to Second Set of Interrogatories (Nos. 12-20, 23-24); Supplemental Responses and Objections to Third Set of Interrogatories (Nos. 25, 27); Second Supplemental Responses and Objections to Second Set of Requests for Admission (Nos. 10, 11, 13); First Supplemental Responses and Objections to Third Set of Requests for Admission (Nos. 24, 31) and Fourth Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy) (Entered: 03/11/2021)
2021-03-11
1
NOTICE OF SERVICE of Genentech, Inc.'s Supplemental Objections and Responses to Baxalta Incorporated's and Baxalta GmbH's First Set of Interrogatories (Nos. 3, 8, 11, 12 & 15-20) filed by Genentech, Inc..(Mayo, Andrew) (Entered: 03/11/2021)
2021-03-11
1
STIPULATION Regarding Supplementation of Protective Order, by Genentech, Inc.. (Balick, Steven) (Entered: 04/02/2021)
2021-04-02
1
ORDER Approving D.I. 399 Supplementation of Protective Order (Supplementing D.I. 316 ). Signed by Judge Timothy Belcher Dyk on 4/5/2021. (kmd) (Entered: 04/05/2021)
2021-04-05
1
MOTION for Pro Hac Vice Appearance of Attorney Wan-Shon Lo - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certification)(Dudash, Amy) (Entered: 07/12/2021)
2021-07-12
1
ORDER granting 401 MOTION for Pro Hac Vice Appearance of Attorney Wan-Shon Lo. Signed by Judge Timothy Belcher Dyk on 7/12/2021. (nmg) (Entered: 07/12/2021)
2021-07-12
1
Add Attorneys - PHV only
2021-07-13
1
No Actions
Pro Hac Vice Attorney Wan-Shon Lo for Baxalta GmbH, and for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
2021-07-13
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Catherine Nyarady - filed by Genentech, Inc.. (Balick, Steven) (Entered: 07/23/2021)
2021-07-23
1
ORDER, granting D.I. 403 Motion to Appear Pro Hac Vice Appearance of Attorney Catherine Nyarady. Signed by Judge Timothy Belcher Dyk on 7/27/2021. (myr) (Entered: 07/27/2021)
2021-07-27
1
Pro Hac Vice Attorney Catherine Nyarady for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
2021-07-28
1
No Actions
Add Attorneys - PHV only
2021-07-28
1
No Actions
STIPULATION Regarding Briefing of Dispositive Motions, by Genentech, Inc.. (Balick, Steven) (Entered: 08/24/2021)
2021-08-24
1
STIPULATION AND ORDER re D.I. 405 . Signed by Judge Timothy Belcher Dyk on 08/25/2021. (smg) (Entered: 08/25/2021)
2021-08-25
1
MOTION for Summary Judgment - filed by Genentech, Inc.. (Attachments: # 1 Text of Proposed Order)(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] OPENING BRIEF in Support re 407 MOTION for Summary Judgment filed by Genentech, Inc..Answering Brief/Response due date per Local Rules is 9/17/2021. (Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of David E. Cole, Volume 1 of 2) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-14 (Volume 1 of 2))(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of David E. Cole, Volume 2 of 2) by Genentech, Inc.. (Attachments: # 1 Exhibit 15-28 (Volume 2 of 2))(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of John P. Sheehan, M.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-2)(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of Stephanie A. Smith, D.V.M., M.S.) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-2)(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-3)(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of Guy A. Young, M.D.) by Genentech, Inc.. (Attachments: # 1 Exhibit 1)(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
[SEALED] DECLARATION re 408 Opening Brief in Support (Declaration of Dr. K. Christopher Garcia) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-2)(Balick, Steven) (Entered: 09/03/2021)
2021-09-03
1
REDACTED VERSION of 408 Opening Brief in Support by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 409 Declaration of David E. Cole (Volume 1 of 2) by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 410 Declaration of David E. Cole (Volume 2 of 2) by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 411 Declaration of John P. Sheehan, M.D. by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 412 Declaration of Stephanie A. Smith, D.V.M., M.S. by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 413 Declaration of William R. Strohl, Ph.D. by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 414 Declaration of Guy A. Young, M.D. by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
REDACTED VERSION of 415 Declaration of Dr. K. Christopher Garcia by Genentech, Inc.. (Mayo, Andrew) (Entered: 09/10/2021)
2021-09-10
1
[SEALED] ANSWERING BRIEF in Opposition re 407 MOTION for Summary Judgment filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 10/8/2021. (Attachments: # 1 Index of Exhibits, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Certificate of Service)(Dudash, Amy) (Entered: 10/01/2021)
2021-10-01
1
[SEALED] REPLY BRIEF re 407 MOTION for Summary Judgment filed by Genentech, Inc.. (Balick, Steven) (Entered: 10/15/2021)
2021-10-15
1
REDACTED VERSION of 425 Reply Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 10/22/2021)
2021-10-22
1
REDACTED VERSION of 424 Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28)(Dudash, Amy) (Entered: 10/27/2021)
2021-10-27
1
MOTION for Pro Hac Vice Appearance of Attorney William R. Peterson - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certification by Counsel to be Admitted Pro Hac Vice)(Dudash, Amy) (Entered: 10/27/2021)
2021-10-27
1
SO ORDERED, re 428 MOTION for Pro Hac Vice Appearance of Attorney William R. Peterson filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 10/29/2021. (myr)
2021-10-29
1
No Actions
SO ORDERED
2021-10-29
1
No Actions
Add Attorneys - PHV only
2021-10-29
1
No Actions
Pro Hac Vice Attorney William R. Peterson for Baxalta GmbH and Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
2021-10-29
1
No Actions
MOTION to Seal Courtroom and Transcript Regarding Summary Judgment Hearing (UNOPPOSED) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 11/18/2021)
2021-11-18
1
[SEALED] MEMORANDUM in Support re 429 MOTION to Seal Courtroom and Transcript Regarding Summary Judgment Hearing (UNOPPOSED) filed by Genentech, Inc..Answering Brief/Response due date per Local Rules is 12/2/2021. (Balick, Steven) (Entered: 11/18/2021)
2021-11-18
1
Minute Entry for proceedings held before Judge Timothy Belcher Dyk. Motion Hearing re 407 Motion for Summary Judgment held on 11/19/2021, at 10:00 AM. As stated on the record, 429 Genentechs Motion to Seal is DENIED. Parties to file stipulation by 12/03/21. (Court reporter was present) (nmg)
2021-11-22
1
No Actions
Motion Hearing
2021-11-22
1
No Actions
Official Transcript of Hearing held on 11/19/2021 before Judge Timothy B. Dyk. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/15/2021. Redacted Transcript Deadline set for 12/27/2021. Release of Transcript Restriction set for 2/22/2022. (cna, ) (Entered: 11/29/2021)
2021-11-24
1
REDACTED VERSION of 430 MEMORANDUM in Support, by Genentech, Inc.. (Mayo, Andrew) (Entered: 11/29/2021)
2021-11-29
1
[SEALED] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/01/2021)
2021-12-01
1
CERTIFICATE OF SERVICE of Proposed Final Pretrial Order and Exhibits 1-6 by Baxalta GmbH, Baxalta Incorporated re 433 Proposed Pretrial Order (Dudash, Amy) (Entered: 12/01/2021)
2021-12-01
1
MOTION to Seal (Unopposed Renewed and Narrowed Motion to Seal Portions of Summary Judgment Hearing Transcript) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/02/2021)
2021-12-02
1
[SEALED] MEMORANDUM in Support re 435 MOTION to Seal (Unopposed Renewed and Narrowed Motion to Seal Portions of Summary Judgment Hearing Transcript) filed by Genentech, Inc..Answering Brief/Response due date per Local Rules is 12/16/2021. (Attachments: # 1 Exhibit A)(Balick, Steven) (Entered: 12/02/2021)
2021-12-02
1
STIPULATION of Fact Regarding Hybridoma Technology and the Number of Anti-Factor IX/IXa Antibodies Disclosed In The '590 Patent, by Genentech, Inc.. (Balick, Steven) (Entered: 12/03/2021)
2021-12-03
1
[SEALED] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Text of Proposed Order, # 10 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Text of Proposed Order, # 6 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Text of Proposed Order, # 10 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Text of Proposed Order, # 5 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Text of Proposed Order, # 4 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude the Opinions of Baxalta's Expert Witness Dr. Jeffrey J. Gray and Related Opinions of Baxalta's Expert Witness Dr. Wayne A. Marasco) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco) - filed by Genentech, Inc.. (Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] DECLARATION (Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions, Volume I of II) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-37)(Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Text of Proposed Order)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] DECLARATION (Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions, Volume II of II), by Genentech, Inc.. (Attachments: # 1 Exhibit 38-57)(Balick, Steven) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Text of Proposed Order, # 3 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Text of Proposed Order, # 9 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Text of Proposed Order, # 4 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
[SEALED] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Text of Proposed Order, # 7 Certificate of Service)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
1
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
2
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
2
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
2
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
2
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
2
REDACTED VERSION of 433 Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Dudash, Amy) (Entered: 12/08/2021)
2021-12-08
2
REDACTED VERSION of 436 MEMORANDUM in Support, by Genentech, Inc.. (Balick, Steven) (Entered: 12/09/2021)
2021-12-09
1
Joint STIPULATION of Fact Regarding Hybridoma Technology and the Number of Anti-Factor IX/IXa Antibodies Disclosed In The '590 Patent. Signed by Judge Timothy Belcher Dyk on 12/13/2021. (nmg) (Entered: 12/13/2021)
2021-12-13
1
REDACTED VERSION of 441 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 443 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 444 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 445 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 446 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 447 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 448 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 451 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 452 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 453 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco) by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 454 Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions (Volume I of II) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-37)(Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 456 Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions (Volume II of II) by Genentech, Inc.. (Attachments: # 1 Exhibit 38-57)(Mayo, Andrew) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 438 MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 439 MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 440 MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 442 MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 449 MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 457 MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 458 MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 459 MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
REDACTED VERSION of 460 MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Text of Proposed Order)(Dudash, Amy) (Entered: 12/15/2021)
2021-12-15
1
[SEALED] ANSWERING BRIEF in Opposition re 441 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 443 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 444 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 445 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 438 MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 439 MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 440 MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 446 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 442 MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 449 MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 447 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
ANSWERING BRIEF in Opposition re 455 MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 457 MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 448 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 458 MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 450 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude the Opinions of Baxalta's Expert Witness Dr. Jeffrey J. Gray and Related Opinions of Baxalta's Expert Witness Dr. Wayne A. Marasco) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 459 MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 460 MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] DECLARATION of Naz Wehrli in Support of Genentech, Inc.'s Oppositions to Baxalta's Motions In Limine and Daubert Motions by Genentech, Inc.. (Attachments: # 1 Exhibit 1-28)(Balick, Steven) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 451 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 452 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] ANSWERING BRIEF in Opposition re 453 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco) filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 12/27/2021. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Certificate of Service)(Dudash, Amy) (Entered: 12/16/2021)
2021-12-16
1
[SEALED] Joint MOTION to Postpone Jury Trial - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 441 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A-B)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 443 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 444 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
REPLY BRIEF re 445 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody) filed by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 446 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A-D)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 447 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A-C)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 448 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman) filed by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 450 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude the Opinions of Baxalta's Expert Witness Dr. Jeffrey J. Gray and Related Opinions of Baxalta's Expert Witness Dr. Wayne A. Marasco) filed by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 451 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A-B)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 452 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski) filed by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 453 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco) filed by Genentech, Inc.. (Attachments: # 1 Exhibit A)(Mayo, Andrew) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 438 MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 439 MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
REPLY BRIEF re 440 MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 442 MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 449 MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 455 MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
REPLY BRIEF re 457 MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 458 MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 459 MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
[SEALED] REPLY BRIEF re 460 MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Certificate of Service)(Dudash, Amy) (Entered: 12/23/2021)
2021-12-23
1
ORAL ORDER granting 507 the parties Joint Motion to Postpone Trial. The Pretrial Conference scheduled for January 19, 2022, and the Trial scheduled for January 24, 2022, are hereby postponed. Ordered by Judge Timothy B. Dyk on 12/23/2021. (smg)
2021-12-23
1
No Actions
REDACTED VERSION of 489 Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 490 Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 491 Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 493 Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 494 Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 497 Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 499 Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 501 Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 502 Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 503 Declaration of Naz Wehrli by Genentech, Inc.. (Attachments: # 1 Exhibit 1-28)(Mayo, Andrew) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 485 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 486 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 487 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 488 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 492 Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 495 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 498 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 500 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 504 Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 505 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
REDACTED VERSION of 506 Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Dudash, Amy) (Entered: 12/27/2021)
2021-12-27
1
1 - Terminate Deadlines AND Oral Order AND 1 - Terminate Hearings
2021-12-27
1
No Actions
1 - Terminate Hearings AND Oral Order AND 1 - Terminate Deadlines
2021-12-27
1
No Actions
1 - Terminate Hearings AND 1 - Terminate Deadlines AND Oral Order
2021-12-27
1
No Actions
1 - Terminate Deadlines AND 1 - Terminate Hearings AND Oral Order
2021-12-27
1
No Actions
REDACTED VERSION of 508 Reply Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 509 Reply Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 510 Reply Brief, by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 512 Reply Brief, by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 513 Reply Brief, by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 514 Reply Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 515 Reply Brief, by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 516 Reply Brief, by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 517 Reply Brief by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 518 Reply Brief, by Genentech, Inc.. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
[SEALED] MEMORANDUM in Support re 519 Reply Brief [CORRECTED D.I. 519, Reply in Support of Baxalta's Motion in Limine No. 1 to Exclude Evidence of Post-Priority Date Development Efforts] filed by Baxalta GmbH, Baxalta Incorporated.Answering Brief/Response due date per Local Rules is 1/18/2022. (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Dudash, Amy) (Entered: 01/03/2022)
2022-01-03
1
[SEALED] EXHIBIT re 528 Reply Brief, [Corrected Exhibit A to Baxalta's Reply in Support of Its Motion to Exclude Certain Opinions and Testimony of Dr. Douglad M. Monroe, III] by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Certificate of Service)(Dudash, Amy) (Entered: 01/03/2022)
2022-01-03
1
REQUEST for Oral Argument by Genentech, Inc. re 450 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude the Opinions of Baxalta's Expert Witness Dr. Jeffrey J. Gray and Related Opinions of Baxalta's Expert Witness Dr. Wayne A. Marasco), 442 MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra, 446 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas), 441 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement), 440 MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit, 451 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy), 458 MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young, 455 MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials, 447 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives), 445 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody), 443 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness), 448 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman), 460 MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III, 444 MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions), 457 MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness, 453 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco), 459 MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning, 452 MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski), 438 MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts, 439 MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness, 449 MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense. (Mayo, Andrew) (Entered: 01/03/2022)
2022-01-03
1
REDACTED VERSION of 520 Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1)(Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 522 Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 523 Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 524 Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1)(Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 526 Reply Brief by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 527 Reply Brief by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit 1)(Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 528 Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
REDACTED VERSION of 560 MEMORANDUM in Support, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # 1 Exhibit A)(Dudash, Amy) (Entered: 01/04/2022)
2022-01-04
1
ORDER denying 435 Motion to Seal. (See Order for further details). Signed by Judge Timothy Belcher Dyk on 01/05/2022. (smg) (Entered: 01/06/2022)
2022-01-05
1
NOTICE requesting Clerk to remove Alexander F. Atkins as co-counsel.. (Mayo, Andrew) (Entered: 01/12/2022)
2022-01-12
1
[UNSEALED] MEMORANDUM OPINION. Signed by Judge Timothy Belcher Dyk on 1/13/2022.This order has been emailed to local counsel. (myr) (Entered: 01/13/2022)
2022-01-13
1
[UNSEALED] MEMORANDUM OPINION. Signed by Judge Timothy Belcher Dyk on 1/13/2022.This order has been emailed to local counsel. (myr) (Entered: 01/13/2022)
2022-01-13
2
ORDER granting 407 Genentech Inc.'s Motion for Summary Judgment. See the accompanying Memorandum Opinion for additional details. The parties shall meet and confer and propose any redactions to the Memorandum Opinion on or before January 18, 2022. Signed by Judge Timothy Belcher Dyk on 1/13/2022. (myr) (Entered: 01/13/2022)
2022-01-13
1
ORAL ORDER. In light of the court's 574 Order granting Genentech Inc.'s Motion for Summary Judgment, the parties' outstanding pre-trial motions, ECF Nos. 438-453, 455, 457-460, are hereby denied as moot. Entered by Judge Timothy Belcher Dyk on 1/13/2022. (nmg) (Entered: 01/13/2022)
2022-01-13
1
Oral Order
2022-01-13
1
No Actions
Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding the Parties' Joint Position Concerning Redaction of the Court's January 13, 2022 Memorandum Opinion (D.I 573). (Balick, Steven) (Entered: 01/18/2022)
2022-01-18
1
ORAL ORDER: In light of 576 the parties' January 18, 2022, Letter informing the court that they have not requested redactions to the January 13, 2022, Memorandum Opinion, the clerk is hereby directed to unseal the Memorandum Opinion 573 in its entirety. Signed by Judge Timothy Belcher Dyk on 1/19/2022. (myr) (Entered: 01/19/2022)
2022-01-19
1
Remark
2022-01-19
1
No Actions
Oral Order
2022-01-19
1
No Actions
Remark: D.I. 573 Memorandum Opinion UNSEALED per Oral Order D.I. 577 (myr)
2022-01-19
1
No Actions
NOTICE OF APPEAL to the Federal Circuit of 574 Order on Motion for Summary Judgment, 573 Memorandum Opinion . Appeal filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 02/08/2022)
2022-02-08
1
APPEAL - Credit Card Payment of $505.00 received re 578 Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. ( Filing fee $505, receipt number ADEDC-3798835.) (Dudash, Amy)
2022-02-08
1
No Actions
- APPEAL - Credit Card Payment (Attorneys Only)
2022-02-09
1
No Actions
USCA Notice of Appeal and Docket Transmitted
2022-02-09
1
No Actions
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 578 Notice of Appeal (Federal Circuit). (srs)
2022-02-09
1
No Actions
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 578 Notice of Appeal (Federal Circuit) filed by Baxalta GmbH and Baxalta Incorporated. USCA Case Number 22-1461. (nmg) (Entered: 02/10/2022)
2022-02-10
1
TRANSCRIPT REQUEST by Baxalta GmbH, Baxalta Incorporated TRANSCRIPT IS ALREADY ON FILE (Dudash, Amy) (Entered: 02/24/2022)
2022-02-24
1
CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel)
2022-03-31
1
No Actions
Case No Longer Referred to Mediation - Magistrate Judge only
2022-03-31
1
No Actions
CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel)
2022-03-31
1
No Actions
NOTICE requesting Clerk to remove Marissa C.M. Doran as co-counsel.. (Balick, Steven) (Entered: 04/29/2022)
2022-04-29
1
MANDATE of USCA as to 578 Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Decision: AFFIRMED. (Attachments: # 1 Opinion, # 2 Judgment)(smg) (Entered: 10/27/2023)
2023-10-27
1
STIPULATION to Extend Deadline to File Bill of Costs by Genentech, Inc.. (Mayo, Andrew) (Entered: 11/10/2023)
2023-11-10
1
SO ORDERED, re D.I. 583 STIPULATION to Extend Deadline to File Bill of Costs by Genentech, Inc. The deadline for Defendant Genentech, Inc. to file a bill of costs is on or before December 8, 2023. Signed by Judge Timothy Belcher Dyk on 11/14/2023. (smg) (Entered: 11/14/2023)
2023-11-14
1
BILL OF COSTS by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/08/2023)
2023-12-08
1
[SEALED] MEMORANDUM in Support of Bill of Costs (D.I. 585) filed by Genentech, Inc..Answering Brief/Response due date per Local Rules is 12/26/2023. (Mayo, Andrew) (Entered: 12/08/2023)
2023-12-08
1
[SEALED] DECLARATION re 586 MEMORANDUM in Support (of Eric Alan Stone) by Genentech, Inc.. (Attachments: # 1 Exhibit 1-40, # 2 Exhibit 41-80, # 3 Exhibit 81-102, # 4 Exhibit 103-130)(Mayo, Andrew) (Entered: 12/08/2023)
2023-12-08
1
REDACTED VERSION of 586 MEMORANDUM in Support by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2023)
2023-12-15
1
REDACTED VERSION of 587 Declaration of Eric Alan Stone by Genentech, Inc.. (Mayo, Andrew) (Entered: 12/15/2023)
2023-12-15
1
STIPULATION TO EXTEND TIME to respond to Defendant Genentech, Inc.'s Bill of Costs and supporting documentation to January 15, 2024 - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 12/28/2023)
2023-12-28
1
SO ORDERED, re D.I. 590 STIPULATION TO EXTEND TIME to respond to Defendant Genentech, Inc.'s Bill of Costs and supporting documentation to January 15, 2024 filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 12/29/2023. (mpb) (Entered: 12/29/2023)
2023-12-29
1
STIPULATION TO EXTEND TIME to respond to Defendant Genentech, Inc.'s Bill of Costs and supporting documentation to January 22, 2024 - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/17/2024)
2024-01-17
1
ORDER re D.I. 592 STIPULATION TO EXTEND TIME to respond to Defendant Genentech, Inc.'s Bill of Costs and supporting documentation to January 22, 2024 filed by Baxalta GmbH and Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 1/18/2024. (nmg) (Entered: 01/18/2024)
2024-01-18
1
STIPULATION TO EXTEND TIME to respond to Defendant Genentech, Inc.'s Bill of Costs and supporting documentation to January 26, 2024 - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 01/23/2024)
2024-01-23
1
ORDER re D.I. 594 STIPULATION TO EXTEND TIME to respond to Defendant Genentech, Inc.'s Bill of Costs and supporting documentation to January 26, 2024 filed by Baxalta GmbH and Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 1/23/2024. (nmg) (Entered: 01/23/2024)
2024-01-23
1
ORDER: By February 20, 2024, in a letter not to exceed 2 double-spaced pages, Plaintiffs should explain why pursuant to Local Rule 54.1 the Court should not consider the Plaintiffs to have waived any objection to the Bill of Costs as filed so that the clerk may proceed to consider and award costs as allowed. Signed by Judge Timothy Belcher Dyk on 2/13/2024. (mpb) (Entered: 02/13/2024)
2024-02-13
1
Letter to the Honorable Timothy B. Dyk from Amy M. Dudash regarding Order dated February 13, 2024. (Dudash, Amy) (Entered: 02/14/2024)
2024-02-14
1
STIPULATION of Dismissal by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy) (Entered: 02/21/2024)
2024-02-21
1
Stipulation and Order AND ~Util - Terminate Civil Case
2024-02-22
1
Patent/Trademark Report to Commissioner of Patents
2024-02-22
1